<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq:Pyt (Medicine-3) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Night PYQ
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">50</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 11523,
    "choices": [
      {
        "id": 46058,
        "text": "<p><span style=\"font-size:12.0pt;\">MS</span></p>"
      },
      {
        "id": 46059,
        "text": "<p><span style=\"font-size:12.0pt;\">ALS</span></p>"
      },
      {
        "id": 46060,
        "text": "<p><span style=\"font-size:12.0pt;\">GBS</span></p>"
      },
      {
        "id": 46061,
        "text": "<p><span style=\"font-size:12.0pt;\">Tropical spastic paraparesis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male patient presented with a history of bilateral lower limb weakness which progressed to his upper limbs in a year. On examination, he had weakness in both lower limbs and wasting in the left upper limb. Babinski sign was positive and the deep tendon reflexes were absent. He has no sensory loss or any autonomic dysfunction. What is the likely diagnosis? (INICET MAY 2021)</span></p>",
    "unique_key": "Q1822582",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012220,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;B) ALS</strong></span></p><p><br><span style=\"font-size:12pt;\">Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by mixed upper and lower motor neuron signs. The presence of both Babinski sign (an upper motor neuron sign) and absent deep tendon reflexes (a lower motor neuron sign), along with the chronic progression and lack of sensory/autonomic involvement, strongly points towards ALS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:12pt;\"><strong>Option A. MS:</strong> Multiple sclerosis typically involves sensory symptoms and demyelinating plaques visible on MRI, which are not described here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. GBS:</strong> Guillain-Barr\u00e9 Syndrome is an acute condition with a rapid onset and is primarily a lower motor neuron disease without upper motor neuron signs like the Babinski reflex.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Tropical spastic paraparesis:</strong> This condition is associated with HTLV-1 infection and presents predominantly with upper motor neuron signs, not the mixed signs seen in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">ALS presents with both upper and lower motor neuron signs, progressive weakness, and no sensory or autonomic dysfunction.</span></p>",
    "correct_choice_id": 46059,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 46986,
    "choices": [
      {
        "id": 187559,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti-actin antibodies</span></p>"
      },
      {
        "id": 187560,
        "text": "<p><span style=\"font-size:12.0pt;\">Antinuclear antibodies</span></p>"
      },
      {
        "id": 187561,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti-mitochondrial antibodies</span></p>"
      },
      {
        "id": 187562,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti-soluble liver antigen antibodies</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The antibodies typically elevated in primary biliary cirrhosis are? (NEET PG 2017)</span></p>",
    "unique_key": "Q7120871",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012224,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><strong>Ans. C) Anti-mitochondrial antibodies</strong></p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Anti-mitochondrial antibodies (AMA) are the hallmark serological marker for primary biliary cirrhosis (now termed primary biliary cholangitis). These antibodies are highly specific, with &gt;95% of patients having AMA directed against the PDC-E2 pattern. The presence of these antibodies, along with elevated IgM levels and compatible histology, represents the classic diagnostic triad for this condition.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Anti-actin antibodies</strong>: These antibodies (smooth muscle antibodies) are characteristic of autoimmune hepatitis type I, not primary biliary cholangitis. Smooth muscle antibodies (SMA) are typically seen in autoimmune hepatitis along with antinuclear antibodies.</p><p>&nbsp;</p><p><strong>Option B. Antinuclear antibodies</strong>: While antinuclear antibodies may be present in some patients with primary biliary cholangitis, they are more characteristic of autoimmune hepatitis type I, particularly with a homogeneous pattern.</p><p>&nbsp;</p><p><strong>Option D. Anti-soluble liver antigen antibodies</strong>: These antibodies are associated with autoimmune hepatitis type III, not primary biliary cholangitis. Anti-SLA serves as a marker for this subtype of autoimmune hepatitis.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Primary biliary cholangitis (formerly called primary biliary cirrhosis) has a highly specific serological marker - anti-mitochondrial antibodies - which are found in &gt;95% of patients and target the PDC-E2 pattern, making them a valuable diagnostic tool for this condition.</span></p>",
    "correct_choice_id": 187561,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "InvestigationBased",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11252,
    "choices": [
      {
        "id": 44974,
        "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin</span></span></p>"
      },
      {
        "id": 44975,
        "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroxine</span></span></p>"
      },
      {
        "id": 44976,
        "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Growth hormone</span></span></p>"
      },
      {
        "id": 44977,
        "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adiponectin</span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The production of which of the following hormones is increased in obesity? (NEET PG 2019)</span></span></p>",
    "unique_key": "Q5894239",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012180,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Insulin</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In obesity, there is typically an increase in insulin production due to insulin resistance. This resistance at the cellular level leads to impaired glucose uptake by cells, prompting the pancreas to secrete more insulin in an attempt to maintain normal blood glucose levels&mdash;a state referred to as compensatory hyperinsulinemia. Over time, this can strain the pancreas and exacerbate metabolic issues.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Thyroxine:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroxine levels are generally not increased in obesity; thyroid function can sometimes be altered, but not in the manner of increased production directly due to obesity.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Growth hormone:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Growth hormone levels are often decreased in obesity. Growth hormone has lipolytic effects, helping to break down fats, and its lower levels in obesity are associated with an adverse metabolic profile.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Adiponectin:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a hormone produced by adipose tissue that enhances insulin sensitivity and has anti-inflammatory effects. Levels of adiponectin are typically lower in individuals with obesity, which contributes to increased insulin resistance.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In obesity, insulin resistance occurring due defect at receptors which causes compensatory hyperinsulinemia. Thyroxine, growth hormone, and adiponectin have lipolytic effects, hence, their levels are reduced in obesity.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Obesity</span></span></strong></span></span></p>",
    "correct_choice_id": 44974,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11607,
    "choices": [
      {
        "id": 46394,
        "text": "<p><span style=\"font-size:12.0pt;\">Guillain-Barre syndrome</span></p>"
      },
      {
        "id": 46395,
        "text": "<p><span style=\"font-size:12.0pt;\">Spinal muscular atrophy</span></p>"
      },
      {
        "id": 46396,
        "text": "<p><span style=\"font-size:12.0pt;\">Duchenne muscular dystrophy</span></p>"
      },
      {
        "id": 46397,
        "text": "<p><span style=\"font-size:12.0pt;\">Myasthenia gravis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Tongue fasciculations are seen in:</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
    "unique_key": "Q4467732",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012172,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B) Spinal muscular atrophy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tongue fasciculations are indicative of a lower motor neuron lesion, often associated with disorders that affect the anterior horn cells in the spinal cord or the motor neurons in the brainstem.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Spinal muscular atrophy (SMA):</strong> This condition is characterized by the degeneration of anterior horn cells in the spinal cord and motor nuclei in the lower brainstem. This degeneration leads to muscle weakness and atrophy, including the muscles of the tongue, resulting in tongue fasciculations. SMA is divided into several types based on the age of onset and severity, but fasciculations are a common feature across these types.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Guillain-Barre syndrome:</strong> This is an acute inflammatory demyelinating polyneuropathy that primarily affects the peripheral nerves. It does not typically cause fasciculations, as it is more associated with rapidly progressive weakness and areflexia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Duchenne muscular dystrophy:</strong> This is a genetic disorder characterized by progressive muscle degeneration and weakness. It primarily affects the skeletal muscles, and while it leads to muscle weakness, it does not typically cause fasciculations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Myasthenia gravis:</strong> This is an autoimmune disorder affecting the neuromuscular junction. It leads to fluctuating muscle weakness and fatigability but does not involve lower motor neurons or cause fasciculations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tongue fasciculations are a clinical sign associated with spinal muscular atrophy due to the involvement of lower motor neurons</span></p>",
    "correct_choice_id": 46395,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54262,
    "choices": [
      {
        "id": 216517,
        "text": "<p><span style=\"font-size:12.0pt;\">Evolocumab</span></p>"
      },
      {
        "id": 216518,
        "text": "<p><span style=\"font-size:12.0pt;\">Ezetimibe</span></p>"
      },
      {
        "id": 216519,
        "text": "<p><span style=\"font-size:12.0pt;\">Evinacumab</span></p>"
      },
      {
        "id": 216520,
        "text": "<p><span style=\"font-size:12.0pt;\">Everolimus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a PCSK-9 inhibitor?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q2206072",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012214,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A) Evolocumab</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PCSK-9 inhibitors are a class of drugs that significantly lower LDL cholesterol levels by inhibiting the protein PCSK-9, which in turn increases the number of LDL receptors available to clear LDL cholesterol from the blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">There are only 2 PCSK-9 inhibitors: Evolocumab and alirocumab. Among the options provided:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Evolocumab is a well-known PCSK-9 inhibitor used in modern clinical practice to manage hyperlipidemia, particularly in patients with familial hypercholesterolemia or those who are at high risk of cardiovascular events.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.</strong> <strong>Ezetimibe</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Ezetimibe is an NPC1L1 transport inhibitor, also known as an intestinal cholesterol absorption inhibitor. It reduces blood cholesterol by decreasing the absorption of cholesterol in the small intestine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Evinacumab</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Evinacumab is a newer drug that acts as an ANGPTL3 inhibitor. It is specifically approved for use in patients with familial homozygous type 2 hyperlipidemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Everolimus</strong>:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Everolimus is an mTOR inhibitor and an immunosuppressive drug used primarily in organ transplantation and certain types of cancer. It is not related to the treatment of dyslipidemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Evolocumab is a PCSK-9 inhibitor used to significantly lower LDL cholesterol levels, particularly in high-risk patients.</span></p>",
    "correct_choice_id": 216517,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24776,
    "choices": [
      {
        "id": 99065,
        "text": "<p><span style=\"font-size:11.0pt;\">Left motor cortex</span></p>"
      },
      {
        "id": 99066,
        "text": "<p><span style=\"font-size:11.0pt;\">Right motor cortex</span></p>"
      },
      {
        "id": 99067,
        "text": "<p><span style=\"font-size:11.0pt;\">Left posterior parietal area</span></p>"
      },
      {
        "id": 99068,
        "text": "<p><span style=\"font-size:11.0pt;\">Right posterior parietal area</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A person comes to the OPD with symptoms of not using his left side and not washing the left side of his body while bathing. On examination he wasn't able to draw the left side of the images. Which of the following is the most likely location of the lesion? (INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-152753.png\" alt=\"\" width=\"300\" height=\"293\"></span></p>",
    "unique_key": "Q6628804",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012170,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D)&nbsp;Right posterior parietal area</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The symptoms described indicate left-sided hemi-neglect, which is typically due to a lesion in the non-dominant (right) posterior parietal area, responsible for spatial awareness and attention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:12pt;\"><strong>Option A. Left motor cortex:</strong> Would result in right-sided motor deficits.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option B. Right motor cortex:</strong> Would result in left-sided motor deficits but not neglect.</span></p><p><br><span style=\"font-size:12pt;\"><strong>Option C. Left posterior parietal area:</strong> Would result in right-sided hemi-neglect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Left-sided neglect is often due to a lesion in the right posterior parietal area.</span></p>",
    "correct_choice_id": 99068,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11293,
    "choices": [
      {
        "id": 45138,
        "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ECG to rule out atrial fibrillation</span></span></p>"
      },
      {
        "id": 45139,
        "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If ECG is normal, CT scan should be done</span></span></p>"
      },
      {
        "id": 45140,
        "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tilt-table testing</span></span></p>"
      },
      {
        "id": 45141,
        "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vestibular neuritis is a possible condition that can cause these symptoms</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man presented with an episode of acute onset dizziness and loss of consciousness which lasted for a few seconds followed by a regain of full consciousness. There were no similar episodes in the past. Which of the following is a true statement regarding this scenario? (NEET PG 2020)</span></span></p>",
    "unique_key": "Q3959800",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012227,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. ECG to rule out atrial fibrillation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An electrocardiogram (ECG) is crucial in the initial evaluation of a patient presenting with syncope, particularly to rule out cardiac causes such as atrial fibrillation, which can lead to episodic reductions in cardiac output and cerebral perfusion. Atrial fibrillation, a common arrhythmia in the elderly, can cause transient episodes of dizziness and loss of consciousness due to irregular and often rapid heart rate leading to ineffective heart pumping.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note -</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In an elderly w/ first episode of syncope detailed history, clinical exam (cardiac, postural BP, neuro exam), basic investigations (ECG, +/- ECHO) is required</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. If ECG is normal, CT scan should be done:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While a CT scan might be considered if there is suspicion of a neurological cause after a thorough clinical evaluation, it is not automatically the next step following a normal ECG, especially in the absence of neurological symptoms or signs suggestive of structural brain disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Tilt-table testing:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is generally reserved for cases where recurrent unexplained episodes of syncope occur, particularly when a vasovagal or orthostatic cause is suspected, not typically used after a first episode unless specific indications are present.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Vestibular neuritis is a possible condition that can cause these symptoms:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vestibular neuritis can cause severe vertigo and imbalance but typically does not cause loss of consciousness, making it less likely in this case.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In elderly patients presenting with an acute onset of dizziness and syncope, an ECG is an essential first step to rule out arrhythmic causes such as atrial fibrillation. Additional diagnostic steps should be guided by the findings of the initial evaluation and specific clinical indicators.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison 21/Atrial fibrillation/Chap 251</span></span></strong></p>",
    "correct_choice_id": 45138,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16173,
    "choices": [
      {
        "id": 64652,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bronchoscopy</span></span></span></p>"
      },
      {
        "id": 64653,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CT guided biopsy</span></span></span></p>"
      },
      {
        "id": 64654,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sputum cytology</span></span></span></p>"
      },
      {
        "id": 64655,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sputum for AFB</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 45-year-old patient with a history of smoking a pack of cigarettes for the past 15 years presents with hemoptysis. CXR shows a 3 cm upper lobe mass near the apex of the lung. What is the next best step for the management of this patient?</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> (FMGE JAN 2023)</span></span></span></p>",
    "unique_key": "Q3953752",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012187,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>B) CT guided biopsy</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The patient has several risk factors for lung cancer, including being over 40 years old, a significant smoking history, and the presence of a mass larger than 2 cm on the chest X-ray. Given these factors, the likelihood of the mass being malignant is high. A <strong>CT guided biopsy is the best next step </strong>because it allows for precise sampling of the mass to confirm the diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Bronchoscopy:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This would be appropriate if the mass were centrally located or if there were signs of endobronchial involvement. However, because the mass is in the upper lobe, CT guided biopsy is preferred.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Sputum cytology:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This test can sometimes detect cancer cells in the sputum, but it is less reliable, especially for peripheral lung lesions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Sputum for AFB:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This test is used to detect tuberculosis. Given the patient&#39;s history and presentation, tuberculosis is less likely than lung cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For a patient with a significant smoking history and a peripheral lung mass larger than 2 cm, a CT guided biopsy is the next best step to diagnose the nature of the mass.</span></span></span></p>",
    "correct_choice_id": 64653,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "FMGE",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11805,
    "choices": [
      {
        "id": 47186,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iloprost</span></span></p>"
      },
      {
        "id": 47187,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ambrisentan</span></span></p>"
      },
      {
        "id": 47188,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nifedipine</span></span></p>"
      },
      {
        "id": 47189,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epoprostenol</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 35-year-old female patient with class II pulmonary hypertension presents with a negative vasoreactivity test. Which of the following is used in the next step of management? (INICET NOV 2021)</span></span></span></p>",
    "unique_key": "Q4761503",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012219,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Ambrisentan</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary arterial hypertension (PAH) management depends on the results of the vasoreactivity test. In patients with a negative vasoreactivity test, calcium channel blockers such as nifedipine are not effective. Instead, treatment typically involves the use of endothelin receptor antagonists, phosphodiesterase-5 inhibitors, or prostanoids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For a patient with WHO functional class II PAH and a negative vasoreactivity test, the next step in management often includes endothelin receptor antagonists like Ambrisentan. Ambrisentan works by blocking the effects of endothelin-1, a potent vasoconstrictor, thereby reducing pulmonary vascular resistance and improving symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Iloprost:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Iloprost is a prostacyclin analog, used primarily in more advanced stages of PAH (class III or IV) or when other treatments have failed. It is not typically the first-line treatment for class II PAH with a negative vasoreactivity test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Nifedipine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Nifedipine, a calcium channel blocker, is used in patients with a positive vasoreactivity test. Since this patient has a negative vasoreactivity test, nifedipine is not appropriate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Epoprostenol:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Epoprostenol is another prostacyclin analog used in advanced PAH (class III or IV) or refractory cases. It is not typically used for initial treatment in class II PAH with a negative vasoreactivity test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In class II and class III pulmonary arterial hypertension (PAH), the best option is to use a combination of a phosphodiesterase inhibitor like Tadalafil and an endothelin receptor antagonist like Ambrisentan. Combination therapy is preferred, even though it may not be listed in all options. For refractory class III and class IV PAH patients, prostanoids are used.</span></span></span></p>",
    "correct_choice_id": 47187,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11616,
    "choices": [
      {
        "id": 46430,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reduce FiO2</span></span></span></p>"
      },
      {
        "id": 46431,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase tidal volume</span></span></span></p>"
      },
      {
        "id": 46432,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase respiratory rate</span></span></span></p>"
      },
      {
        "id": 46433,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase PEEP</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old female patient weighing 60 kg is on mechanical ventilation for ARDS secondary to urosepsis.&nbsp;</span></span></span><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">The respiratory parameters are as follows: tidal volume- 360 mL; frequency- 30 breaths/min; PEEP- 5 cm of H2O; and FiO2- 90%.&nbsp;</span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The arterial blood gas findings are as follows: paO2- 50 mmHg; paCO2- 38 mmHg and pH- 7.38.&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the next step?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
    "unique_key": "Q4970510",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012218,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Increase PEEP</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute Respiratory Distress Syndrome (ARDS) requires careful management of mechanical ventilation settings to optimize oxygenation while minimizing lung injury. The patient&#39;s current settings and blood gas findings suggest hypoxemia (paO2 of 50 mmHg) with an FiO2 of 90%. The goal in managing ARDS is to maintain adequate oxygenation (paO2 &gt; 60 mmHg) while reducing the FiO2 to less than 60% to avoid oxygen toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increasing PEEP is the best option to improve oxygenation. PEEP helps to keep alveoli open, improving gas exchange and oxygenation. By increasing PEEP, we can potentially increase the paO2 and eventually reduce the FiO2 to safer levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Reduce FiO2</strong>: Although reducing FiO2 is a long-term goal to prevent oxygen toxicity, it is not advisable to reduce it immediately because the patient is currently hypoxemic (paO2 of 50 mmHg).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Increase tidal volume</strong>: Not appropriate as it can increase the risk of ventilator-induced lung injury in ARDS patients. The current tidal volume is within the safe range (360 mL), which is appropriate for a 60 kg patient as it falls within the recommended range of 4-6 mL/kg for ARDS patients to prevent ventilator-induced lung injury.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Increase respiratory rate</strong>: Increasing the respiratory rate is not necessary in this situation as the paCO2 (38 mmHg) and pH (7.38) indicate normal ventilation and no significant respiratory acidosis (paCO2 is normal).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In ARDS management, if the patient remains hypoxemic despite a high FiO2, the next step is to increase the PEEP to improve oxygenation while maintaining lung-protective ventilation strategies.</span></span></span></p>",
    "correct_choice_id": 46433,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11798,
    "choices": [
      {
        "id": 47158,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Right to left shunt</span></span></p>"
      },
      {
        "id": 47159,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventilation/Perfusion mismatch</span></span></p>"
      },
      {
        "id": 47160,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypoventilation</span></span></p>"
      },
      {
        "id": 47161,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alveolar membrane damage</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient came with hypoxemia and a normal alveolar-arterial oxygen gradient. What can be the cause? (INICET NOV 2021)</span></span></span></p>",
    "unique_key": "Q8889770",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012173,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Hypoventilation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypoxemia with a normal alveolar-arterial (A-a) oxygen gradient typically points to specific causes where the alveolar oxygen (PAO2) and arterial oxygen (PaO2) levels remain proportionate. In this scenario, the primary causes are hypoventilation and situations involving low inspired oxygen tension (low FiO2).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Hypoventilation:</span></strong><span style=\"font-size:12.0pt\"> This condition leads to hypoxemia due to inadequate ventilation. When ventilation is insufficient, the amount of oxygen entering the alveoli drops, leading to a corresponding decrease in the amount of oxygen diffusing into the blood, resulting in hypoxemia. However, because the underlying issue is with ventilation and not with oxygen diffusion or blood flow, the A-a gradient remains normal.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Low FiO2 or Low Barometric Pressure:</span></strong><span style=\"font-size:12.0pt\"> This can occur in scenarios such as high altitude where the barometric pressure is low, leading to reduced oxygen availability in the air. However, these situations were not explicitly listed among the answer choices.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">According to the reference paragraph, other conditions like ventilation/perfusion (V/Q) mismatch, diffusion limitation, and alveolar membrane damage, cause an increased A-a gradient due to impaired oxygen transfer across the alveolar membrane or mismatched ventilation and perfusion in the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Right to left shunt:</strong> This condition causes hypoxemia due to blood bypassing the lungs and not getting oxygenated. It leads to an increased A-a gradient because the oxygen content of the arterial blood is significantly lower compared to the alveolar oxygen level.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Ventilation/Perfusion mismatch:</strong> This condition results from areas of the lung receiving oxygen but not perfused with blood or areas perfused with blood but not receiving oxygen. It causes an increased A-a gradient due to ineffective oxygen transfer to the blood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Alveolar membrane damage:</strong> This results in impaired oxygen diffusion across the alveolar-capillary membrane, leading to an increased A-a gradient as oxygen transfer from alveoli to blood is hindered.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypoventilation is a primary cause of hypoxemia with a normal alveolar-arterial oxygen gradient.</span></span></span></p>",
    "correct_choice_id": 47160,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 47532,
    "choices": [
      {
        "id": 189739,
        "text": "<p><span style=\"font-size:12.0pt;\">Duke's criteria</span></p>"
      },
      {
        "id": 189740,
        "text": "<p><span style=\"font-size:12.0pt;\">Light criteria</span></p>"
      },
      {
        "id": 189741,
        "text": "<p><span style=\"font-size:12.0pt;\">Beer's criteria</span></p>"
      },
      {
        "id": 189742,
        "text": "<p><span style=\"font-size:12.0pt;\">Jones criteria</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">An elderly male patient who is a known case of COPD, hypertension, and diabetes mellitus visits the OPD to review his medications. Which of the following criteria should be followed by the physician during the review?</span></p>",
    "unique_key": "Q5508303",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012162,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Beer's criteria</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Beer's criteria is a guideline used by physicians to help improve the safety of prescribing medications for older adults. It is specifically designed to <strong>avoid potentially inappropriate medications that can cause adverse drug reactions</strong> and interactions in the <strong>elderly</strong> individuals.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Duke's criteria:&nbsp;</strong>Used for diagnosing infective endocarditis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Light criteria:&nbsp;</strong>Used for diagnosing exudative pleural effusions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Jones criteria:&nbsp;</strong>Used for diagnosing acute rheumatic fever.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Beer's criteria should be used by physicians to review and manage medications in elderly patients to minimize the risk of adverse effects and drug interactions.</span></p>",
    "correct_choice_id": 189741,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11321,
    "choices": [
      {
        "id": 45250,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aschoff nodule</span></span></p>"
      },
      {
        "id": 45251,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pseudomyxoma</span></span></p>"
      },
      {
        "id": 45252,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Caseating granuloma</span></span></p>"
      },
      {
        "id": 45253,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Verrucous tumour</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 17-year-old girl presented with arthritis. She had a history of fever and sore throat 1 week ago. On examination, you hear a pansystolic murmur suggestive of mitral regurgitation. What is the finding you will see in the biopsy?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/24/screenshot-2024-07-24-172510.jpg\" style=\"height:204px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
    "unique_key": "Q3558659",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012228,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Aschoff nodule</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical presentation suggests acute rheumatic fever (ARF), a sequela of untreated or poorly treated streptococcal pharyngitis. ARF can manifest with migratory arthritis, carditis (evidenced by the pansystolic murmur indicative of mitral regurgitation), and other systemic symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aschoff nodules, or Aschoff bodies, are pathognomonic for acute rheumatic fever. These are areas of fibrinoid necrosis surrounded by chronic inflammatory cells, including Anitschkow cells (macrophages with characteristic wavy nuclei). They are found in the heart tissue, especially in the myocardium, and are a hallmark of rheumatic carditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Pseudomyxoma:</span></strong><span style=\"font-size:12.0pt\"> Pseudomyxoma peritonei is a condition characterized by the accumulation of mucinous material in the peritoneal cavity, typically originating from a mucinous tumor. It is not related to acute rheumatic fever.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Caseating granuloma:</span></strong><span style=\"font-size:12.0pt\"> Caseating granulomas are characteristic of tuberculosis and certain fungal infections. They consist of a central area of necrosis surrounded by a rim of activated macrophages and lymphocytes. This finding is not associated with rheumatic fever.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Verrucous tumour:</span></strong><span style=\"font-size:12.0pt\"> Verrucous tumors are typically warty growths and are not related to rheumatic fever. They can be associated with certain types of skin cancers or infectious warts but have no connection to the condition described in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In patients with a history of sore throat followed by symptoms such as arthritis and carditis, acute rheumatic fever should be considered. The presence of Aschoff nodules in biopsy is pathognomonic for this condition, confirming the diagnosis.</span></span></span></p>",
    "correct_choice_id": 45250,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74882,
    "choices": [
      {
        "id": 298429,
        "text": "<p><span style=\"font-size:16px;\">Coagulopathy</span></p>"
      },
      {
        "id": 298430,
        "text": "<p><span style=\"font-size:16px;\">Hearing loss</span></p>"
      },
      {
        "id": 298431,
        "text": "<p><span style=\"font-size:16px;\">Haemodilution</span></p>"
      },
      {
        "id": 298432,
        "text": "<p><span style=\"font-size:16px;\">Visual loss</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A scuba diver surfaces rapidly, soon experiencing joint pain, dizziness, and difficulty breathing indicating decompression sickness. Which of the following is not associated with it? (INICET NOV 2024)</span></p>",
    "unique_key": "Q2271724",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012213,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Haemodilution</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Decompression sickness (DCS), or Caisson disease, occurs due to rapid ascent during diving, based on Henry's law. When pressure decreases rapidly, dissolved gases (particularly nitrogen) form bubbles in blood and tissues. These bubbles can cause vascular occlusions, organ damage, and various systemic manifestations including hemoconcentration\u2014not haemodilution.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Coagulopathy:</strong> Incorrect. Coagulopathy can occur in DCS due to endothelial damage from gas bubbles, causing a DIC-like picture in 2\u20133% of cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Hearing loss:</strong> Incorrect. Hearing loss, though rare, is a possible manifestation of DCS due to inner ear involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Visual loss:</strong> Incorrect. Visual disturbances and loss can occur in DCS due to bubble formation affecting the visual pathways.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Decompression sickness leads to hemoconcentration (not haemodilution) and can present with joint pain (\"the bends\"), neurological symptoms, coagulopathy, and sensory organ dysfunction including vision and hearing loss.</span></p>",
    "correct_choice_id": 298431,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 52811,
    "choices": [
      {
        "id": 210733,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aortic stenosis</span></span></span></p>"
      },
      {
        "id": 210734,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aortic regurgitation</span></span></span></p>"
      },
      {
        "id": 210735,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mitral regurgitation</span></span></span></p>"
      },
      {
        "id": 210736,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tricuspid regurgitation</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male patient presented to the hospital with palpitations. Physical examination showed a diastolic murmur in the left 3rd intercostal space. What is the most likely diagnosis? (NEET PG 2023)</span></span></p>",
    "unique_key": "Q8694801",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012230,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Aortic regurgitation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of a diastolic murmur heard best at the left 3rd intercostal space (Erb&#39;s point) is characteristic of aortic regurgitation. Aortic regurgitation occurs when the aortic valve does not close properly, allowing blood to flow back into the left ventricle during diastole.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Aortic stenosis:</span></strong><span style=\"font-size:12.0pt\"> This condition produces a systolic ejection murmur, typically heard at the right second intercostal space.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Mitral regurgitation:</span></strong><span style=\"font-size:12.0pt\"> This condition causes a pansystolic murmur heard best at the apex of the heart and radiates to the axilla.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Tricuspid regurgitation:</span></strong><span style=\"font-size:12.0pt\"> This condition causes a pansystolic murmur heard best at the lower left sternal border.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aortic Regurgitation&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is associated with a diastolic murmur, best heard at Erb&rsquo;s point (left 3rd intercostal space). The murmur is typically described as a high-pitched, blowing, decrescendo murmur.</span></span></p>",
    "correct_choice_id": 210734,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55351,
    "choices": [
      {
        "id": 220865,
        "text": "<p><span style=\"font-size:12pt;\">Increased afterload</span></p>"
      },
      {
        "id": 220866,
        "text": "<p><span style=\"font-size:12pt;\">Decreased preload</span></p>"
      },
      {
        "id": 220867,
        "text": "<p><span style=\"font-size:12pt;\">High systemic vascular resistance</span></p>"
      },
      {
        "id": 220868,
        "text": "<p><span style=\"font-size:12pt;\">Decreased contractility</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A patient after RTA (Road Traffic Accident) presented with hypovolemic shock. What is the reason for decreased cardiac output in this patient? (FMGE JULY 2024)</span></p>",
    "unique_key": "Q9289820",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012164,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Decreased preload</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hypovolemic shock, often caused by significant blood loss as in the case of a road traffic accident (RTA), leads to a decrease in the volume of blood returning to the heart (preload). Preload is the initial stretching of the cardiac myocytes prior to contraction, which is directly related to the volume of blood filling the heart. When there is a significant loss of blood volume, the preload decreases, leading to a reduced stroke volume and, consequently, decreased cardiac output.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Increased afterload:</strong> This refers to the resistance the heart must overcome to eject blood. Increased afterload is not a primary issue in hypovolemic shock.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. High systemic vascular resistance:</strong> This would be more characteristic of distributive shock, such as septic shock, rather than hypovolemic shock.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Decreased contractility:</strong> While decreased contractility can reduce cardiac output, in hypovolemic shock, the primary problem is the loss of blood volume leading to decreased preload, not a primary issue with the heart muscle's ability to contract.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In hypovolemic shock, the primary cause of decreased cardiac output is decreased preload due to significant loss of blood volume.</span></p>",
    "correct_choice_id": 220866,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 84275,
    "choices": [
      {
        "id": 335680,
        "text": "<p><span style=\"font-size:12.0pt;\">CK-MB</span></p>"
      },
      {
        "id": 335681,
        "text": "<p><span style=\"font-size:12.0pt;\">Troponin T or I</span></p>"
      },
      {
        "id": 335682,
        "text": "<p><span style=\"font-size:12.0pt;\">C-reactive Protein</span></p>"
      },
      {
        "id": 335683,
        "text": "<p><span style=\"font-size:12.0pt;\">LDH</span></p>"
      }
    ],
    "text": "<p>Which of the following is the most reliable marker for diagnosing Acute STEMI specifically in athletes? (NEET PG 2016)</p>",
    "unique_key": "Q2034899",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012223,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><strong>Ans. B) Troponin T or I</strong></p><p>&nbsp;</p><p>Cardiac troponins (specifically troponin I and T) are the most sensitive and specific markers for myocardial necrosis in acute coronary syndromes, including STEMI. Troponin I and T are the preferred biomarkers for diagnosing myocardial injury, with Troponin I having slightly higher cardiac specificity than Troponin T. These biomarkers remain the diagnostic standard regardless of patient population, including athletes.<br><br>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. CK-MB</strong>: While CK-MB is a cardiac marker, it is less sensitive than troponin. It returns to baseline in 48-72 hours and serves better as a marker for re-infarction rather than initial diagnosis. It's problematic in athletes specifically because skeletal muscle damage from exercise can elevate CK-MB, reducing its diagnostic specificity.</p><p><strong>Option C. C-reactive Protein</strong>: CRP is a general inflammatory marker but lacks specificity for cardiac damage. It has no established role in the primary diagnosis of STEMI.</p><p>&nbsp;</p><p><strong>Option D. LDH</strong>: LDH is characterized as a \"Late Cardiac Marker\" that undergoes an \"LDH flip\" (LDH1 &gt; LDH2) in MI. However, it rises too late in the course of myocardial injury to be useful for early diagnosis, and has poor specificity for cardiac damage compared to troponins.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Troponin I and T remain the gold standard biomarkers for diagnosing myocardial infarction, including STEMI, due to their high cardiac specificity and sensitivity, even in athletic populations where other markers may be elevated from exercise.</p>",
    "correct_choice_id": 335681,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "OlderNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 50960,
    "choices": [
      {
        "id": 203381,
        "text": "<p><span style=\"font-size:12.0pt;\">Myocardial infarction&nbsp;</span></p>"
      },
      {
        "id": 203382,
        "text": "<p><span style=\"font-size:12.0pt;\">HOCM&nbsp;</span></p>"
      },
      {
        "id": 203383,
        "text": "<p><span style=\"font-size:12.0pt;\">Brugada syndrome&nbsp;</span></p>"
      },
      {
        "id": 203384,
        "text": "<p><span style=\"font-size:12.0pt;\">DCM</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A young child presented with nocturnal chest pain and a history of syncope has the ECG shown below. What is the most probable diagnosis? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-112958.png\" alt=\"\" width=\"300\" height=\"182\"></span></p>",
    "unique_key": "Q1536223",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012169,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;Brugada syndrome</strong></span></p><p><span style=\"font-size:10pt;\">&nbsp;&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">The ECG provided shows the characteristic pattern of Brugada syndrome, which includes:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Pseudo-right bundle branch block pattern in leads V1 and V2.</span></li><li><span style=\"font-size:12.0pt;\">ST-segment elevation in the right precordial leads (V1-V2).</span></li><li><span style=\"font-size:12.0pt;\">Coving of the ST segment.</span></li><li><span style=\"font-size:12.0pt;\">T-wave inversion following the ST-segment elevation.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Brugada syndrome is a genetic disorder that predisposes individuals to ventricular arrhythmias and sudden cardiac death, often occurring at rest or during sleep. It is more prevalent in young males and can present with symptoms such as nocturnal chest pain, syncope, or sudden cardiac arrest.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Myocardial infarction:&nbsp;</strong>Typically presents with ST-segment elevation in contiguous leads but does not usually show the pseudo-right bundle branch block pattern seen in Brugada syndrome.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. HOCM (Hypertrophic Obstructive Cardiomyopathy):&nbsp;</strong>Characterized by left ventricular hypertrophy and possible left atrial enlargement, often presenting with deep Q waves and signs of left ventricular hypertrophy on ECG, not the specific pattern seen here.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. DCM (Dilated Cardiomyopathy):&nbsp;</strong>Shows global left ventricular dilation and systolic dysfunction, which can lead to low voltage QRS complexes, left bundle branch block, or non-specific ST-T changes but not the specific Brugada pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Brugada syndrome should be suspected in patients, especially young males, with a history of syncope or nocturnal chest pain presenting with the characteristic ECG pattern of pseudo-right bundle branch block and ST-segment elevation in leads V1 and V2.</span></p>",
    "correct_choice_id": 203383,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11256,
    "choices": [
      {
        "id": 44990,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute motor axonal neuropathy</span></span></span></span></p>"
      },
      {
        "id": 44991,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute inflammatory demyelinating polyneuropathy</span></span></span></span></p>"
      },
      {
        "id": 44992,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute motor sensory axonal neuropathy</span></span></span></span></p>"
      },
      {
        "id": 44993,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Miller Fisher syndrome</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the most common type of Guillain-Barre syndrome? (NEET PG 2019)</span></span></p>",
    "unique_key": "Q8007814",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012226,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Acute inflammatory demyelinating polyneuropathy</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute inflammatory demyelinating polyneuropathy (AIDP) is the most common form of Guillain-Barre syndrome (GBS) in the United States and Europe. It presents with rapidly ascending motor weakness and, at times, sensory disturbances in the form of paresthesia. The pathological hallmark of AIDP is the demyelination of peripheral nerves, leading to slow nerve conduction velocities as detected on electromyography.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Acute motor axonal neuropathy (AMAN):&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While AMAN is more common in certain regions like East Asia, it is less prevalent than AIDP in most parts of the world. AMAN is characterized by the involvement of motor fibers without significant demyelination.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Acute motor sensory axonal neuropathy (AMSAN):&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Similar to AMAN but involves both motor and sensory fibers. It is generally more severe but less common than AIDP.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Miller Fisher syndrome:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A rare variant of GBS that is characterized by ataxia, areflexia, and ophthalmoplegia. It is considered a variant of GBS associated with anti-GQ1b antibodies.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AIDP is the <strong>most common type of GBS</strong> presenting with ascending motor weakness with occasional distal sensory paresthesia due to demyelination of posterior column.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Axonal variants:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AMAN (Acute motor axonal neuropathy):&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GM1a, GD1a&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AMSAN (Acute motor &amp; sensory axonal neuropathy):&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GM1a, GD1a&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other variants</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute motor conduction block neuropathy: <strong>GM1a, GD1a</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pharyngo-cervico-branchial variant: <strong>GT1a</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Miller-Fischer variant: <strong>GQ1b &gt;&gt; GT1a</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute ataxic neuropathy: <strong>GQ1b &gt;&gt; GT1a</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pure sensory ataxic variant: <strong>GD1b</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bickerstaff brainstem encephalitis (BBE): <strong>GQ1 &gt;&gt; GT1a</strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Adam and Viktor/Peripheral neuropathy/GBS page 1322</span></span></strong></p>",
    "correct_choice_id": 44991,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11214,
    "choices": [
      {
        "id": 44822,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contralateral loss of joint sense and position</span></span></span></span></p>"
      },
      {
        "id": 44823,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contralateral loss of pain sensation</span></span></span></span></p>"
      },
      {
        "id": 44824,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ipsilateral loss of complete sensory functions</span></span></span></span></p>"
      },
      {
        "id": 44825,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contralateral motor functions </span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which is the characteristic pattern seen in Brown-Sequard syndrome? (NEET PG 2018)</span></span></p>",
    "unique_key": "Q4428191",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012179,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Contralateral loss of pain sensation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brown Sequard syndrome is produced due to <strong>lateral hemi-section of spinal cord</strong>. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features include:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ipsilateral weakness +</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ipsilateral loss of joint position and vibratory sense +</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contralateral loss of pain &amp; temperature sense one or two levels below lesion +</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ipsilateral segmental signs like radicular pain, muscle atrophy, or loss of tendon reflex</span></span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Contralateral loss of joint sense and position:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect, as joint sense and position loss occur ipsilaterally due to dorsal column damage.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Ipsilateral loss of complete sensory functions:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect, sensory loss is not complete and is dissociated; pain and temperature sensations are lost contralaterally while proprioception and vibration are lost ipsilaterally.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Contralateral motor functions:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect, motor function loss (weakness or paralysis) occurs ipsilaterally below the level of the lesion.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In Brown-Sequard syndrome, the characteristic neurological pattern includes ipsilateral motor weakness and proprioceptive loss, alongside contralateral loss of pain and temperature sensation, due to a lateral hemisection of the spinal cord.</span></span></span></span></p>",
    "correct_choice_id": 44823,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11530,
    "choices": [
      {
        "id": 46086,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Start ART if CD4 &lt;200</span></span></span></p>"
      },
      {
        "id": 46087,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Start ART and then ATT after 2 weeks</span></span></span></p>"
      },
      {
        "id": 46088,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Start ATT and then ART after 2 weeks</span></span></span></p>"
      },
      {
        "id": 46089,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Start ATT and ART simultaneously</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A newly diagnosed HIV patient presented with fever, cough, and hemoptysis. His sputum sample showed acid-fast bacilli. What is the appropriate management for this patient? (INICET MAY 2021)</span></span></p>",
    "unique_key": "Q1357664",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012174,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C) Start ATT and then ART after 2 weeks</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In HIV patients with tuberculosis (TB), it is crucial to start antitubercular therapy (ATT) first to reduce the mycobacterial load before initiating antiretroviral therapy (ART). This approach helps to avoid immune reconstitution inflammatory syndrome (IRIS), a life-threatening condition due to massive cytokine response triggered by a rapid increase in CD4 count., which can occur if ART is started too early. The general recommendation is to start ART by 2 weeks -2 months, after ATT initiation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option A. Starting ART only if CD4 &lt;200:</strong> does not address the immediate need for TB treatment. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Starting ART before ATT</strong>: can lead to IRIS. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Starting both therapies simultaneously: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;increases the risk of IRIS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In HIV patients with TB, start ATT first and then initiate ART after 2 weeks-2 months duration.</span></span></span></p>",
    "correct_choice_id": 46088,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 46904,
    "choices": [
      {
        "id": 187231,
        "text": "<p>It is a complication of measles virus infection</p>"
      },
      {
        "id": 187232,
        "text": "<p>Its incidence has decreased after the introduction of vaccination</p>"
      },
      {
        "id": 187233,
        "text": "<p>It most commonly affects individuals between 5 and 15 years old</p>"
      },
      {
        "id": 187234,
        "text": "<p>It typically presents initially with fever and headache</p>"
      }
    ],
    "text": "<p>Which of the following statements about subacute sclerosing panencephalitis (SSPE) is NOT correct? (NEET PG 2015)</p>",
    "unique_key": "Q6521036",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012222,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><strong>Correct Answer: D. It typically presents initially with fever and headache</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>SSPE is a rare, progressive neurological disorder caused by a persistent measles virus infection that leads to brain inflammation and neurodegeneration. The disease typically has an insidious onset with subtle behavioral and intellectual deterioration rather than acute symptoms like fever and headache.</p><p>&nbsp;</p><p>SSPE presents with progressive cognitive decline, personality changes, and school performance deterioration as the initial manifestations. This is followed by myoclonus, ataxia, and eventually a vegetative state. The absence of fever and headache as initial presenting features distinguishes it from acute viral encephalitis.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. It is a complication of measles virus infection:</strong> This statement is correct. SSPE is caused by a persistent infection with a defective measles virus that remains dormant in the CNS for years after the initial infection before causing progressive neurodegeneration.</p><p>&nbsp;</p><p><strong>Option B. Its incidence has decreased after the introduction of vaccination:</strong> This statement is correct. The introduction of measles vaccination has significantly reduced the incidence of SSPE, as preventing the primary measles infection prevents the subsequent development of SSPE.</p><p>&nbsp;</p><p><strong>Option C. It most commonly affects individuals between 5 and 15 years old:</strong> This statement is correct. SSPE typically affects children and adolescents who had measles infection at a very young age, with disease onset usually occurring 6-8 years after the primary infection.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">SSPE presents with insidious behavioral and cognitive changes rather than acute symptoms like fever and headache, and represents a rare but devastating delayed complication of measles virus infection that has become increasingly uncommon due to vaccination.</span></p>",
    "correct_choice_id": 187234,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 84274,
    "choices": [
      {
        "id": 335676,
        "text": "<p><span style=\"font-size:12.0pt;\">Thrombotic Thrombocytopenic Purpura (TTP)</span></p>"
      },
      {
        "id": 335677,
        "text": "<p><span style=\"font-size:12.0pt;\">Disseminated Intravascular Coagulation (DIC)</span></p>"
      },
      {
        "id": 335678,
        "text": "<p><span style=\"font-size:12.0pt;\">HELLP syndrome</span></p>"
      },
      {
        "id": 335679,
        "text": "<p><span style=\"font-size:12.0pt;\">Evan's syndrome</span></p>"
      }
    ],
    "text": "<p>A 25-year-old pregnant woman presents with thrombocytopenia (platelet count &lt; 50,000) and fragmented RBCs in a peripheral smear. Which of the following is the least likely differential diagnosis? (NEET PG 2016)</p>",
    "unique_key": "Q1727408",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012177,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><strong>Ans. D) Evan's syndrome.</strong></p><p>&nbsp;</p><p>Evan's syndrome is characterized by the combination of autoimmune hemolytic anemia (AIHA) with immune thrombocytopenic purpura (ITP) and would be the least likely diagnosis in this case. Evan's syndrome features both conditions simultaneously but does not typically present with fragmented RBCs, which are characteristic of microangiopathic hemolytic anemias. The peripheral smear in Evan's syndrome would show spherocytes from the autoimmune hemolytic component rather than schistocytes (fragmented RBCs).</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><strong>Option A. Thrombotic Thrombocytopenic Purpura (TTP)</strong>: TTP is characterized by thrombocytopenia and microangiopathic hemolytic anemia with schistocytes (fragmented RBCs). The pentad of TTP includes microangiopathic hemolytic anemia, thrombocytopenia, renal failure, neurologic findings, and fever. Pregnancy can be a triggering factor for TTP, making this a very plausible diagnosis in this clinical scenario.</li><li><strong>Option B. Disseminated Intravascular Coagulation (DIC)</strong>:&nbsp; DIC is a common complication in pregnancy, particularly with obstetric complications like abruptio placentae, amniotic fluid embolism, and retained dead fetus syndrome. DIC presents with thrombocytopenia and fragmented RBCs (schistocytes) due to microvascular thrombi. The condition involves abnormal activation of coagulation processes, consumption of clotting factors, and secondary fibrinolysis.</li><li><strong>Option C. HELLP syndrome</strong>: HELLP (Hemolysis, Elevated Liver enzymes, Low Platelets) syndrome is a serious pregnancy complication that features microangiopathic hemolytic anemia with fragmented RBCs and thrombocytopenia. It typically occurs in the third trimester and is considered part of the spectrum of preeclampsia, making it a highly likely diagnosis in this pregnant patient.</li></ul><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Fragmented RBCs (schistocytes) on peripheral blood smear indicate a microangiopathic hemolytic process (as seen in TTP, DIC, and HELLP), whereas Evan's syndrome presents with spherocytes due to its autoimmune hemolytic component without microangiopathy.</p>",
    "correct_choice_id": 335679,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11960,
    "choices": [
      {
        "id": 47805,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rectum</span></span></p>"
      },
      {
        "id": 47806,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colon</span></span></p>"
      },
      {
        "id": 47807,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Small intestine</span></span></p>"
      },
      {
        "id": 47808,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ileocecal junction</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the most common site of abdominal tuberculosis? (INICET NOV 2022)</span></span></span></p>",
    "unique_key": "Q5610317",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012171,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Ileocecal junction</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The ileocecal junction is the most common site of abdominal tuberculosis. This area, which includes the terminal ileum and the beginning of the large intestine (cecum), is particularly susceptible to infection by Mycobacterium tuberculosis. The lymphoid tissue in this region provides a favorable environment for the bacteria to proliferate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Abdominal tuberculosis can present in two primary forms: <strong>hypertrophic and ulcerative. </strong>The hypertrophic form involves thickening of the intestinal wall, while the ulcerative form leads to the formation of ulcers. Clinically, differentiating abdominal tuberculosis from Crohn&#39;s disease can be challenging due to overlapping symptoms and similar radiologic findings. In some cases, empirical anti-tubercular therapy (ATP) may be initiated, with subsequent monitoring for clinical improvement to help distinguish between the two conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Rectum:</span></strong><span style=\"font-size:12.0pt\"> The rectum is not a common site for abdominal tuberculosis. Tuberculosis primarily affects the ileocecal region and less frequently involves other parts of the gastrointestinal tract.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Colon:</span></strong><span style=\"font-size:12.0pt\"> While tuberculosis can affect the colon, it is not the most common site. The ileocecal junction is more frequently involved in abdominal tuberculosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Small intestine:</span></strong><span style=\"font-size:12.0pt\"> Although the small intestine can be affected, the terminal ileum specifically, which is part of the ileocecal junction, is the most common site for tuberculosis within the small intestine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most common site of abdominal tuberculosis is the ileocecal junction, particularly near the terminal ileum. This region&#39;s lymphoid tissue creates a favorable environment for Mycobacterium tuberculosis to proliferate.</span></span></span></p>",
    "correct_choice_id": 47808,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 47610,
    "choices": [
      {
        "id": 190051,
        "text": "<p><span style=\"font-size:12.0pt;\">Cryptococcus neoformans</span></p>"
      },
      {
        "id": 190052,
        "text": "<p><span style=\"font-size:12.0pt;\">Pneumocystis jirovecii</span></p>"
      },
      {
        "id": 190053,
        "text": "<p><span style=\"font-size:12.0pt;\">Tuberculosis</span></p>"
      },
      {
        "id": 190054,
        "text": "<p><span style=\"font-size:12.0pt;\">Pneumococcus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">An HIV patient presents with fever and neck stiffness. Lumbar puncture was done and CSF examination shows lymphocytosis, normal glucose, increased protein and positive India ink staining. What is likely causative organism?&nbsp;</span>(FMGE JANUARY 2024)</p>",
    "unique_key": "Q8029478",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012163,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cryptococcus neoformans</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct answer is Cryptococcus neoformans. The patient presents with signs of meningitis (fever, neck stiffness) and has a cerebrospinal fluid (CSF) profile showing lymphocytosis, normal glucose, increased protein, and positive India ink staining.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cryptococcal meningitis is a common opportunistic infection in HIV patients and is diagnosed by the presence of encapsulated yeast cells seen on India ink staining.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pneumocystis jirovecii:&nbsp;</strong>This organism typically causes pneumonia rather than meningitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Tuberculosis:&nbsp;</strong>Tuberculous meningitis usually presents with low glucose levels in the CSF, which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pneumococcus:&nbsp;</strong>Pneumococcal meningitis typically presents with a neutrophilic CSF rather than lymphocytic CSF.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cryptococcus neoformans is a common cause of meningitis in HIV patients, characterized by lymphocytic CSF, normal glucose, increased protein, and positive India ink staining, which reveals encapsulated yeast cells. \u200b</span></p>",
    "correct_choice_id": 190051,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 84336,
    "choices": [
      {
        "id": 335916,
        "text": "<p>Rhabdomyomas of the heart</p>"
      },
      {
        "id": 335917,
        "text": "<p>Angiofibromas on the face</p>"
      },
      {
        "id": 335918,
        "text": "<p>Fibromas around the nails</p>"
      },
      {
        "id": 335919,
        "text": "<p>Angiomyolipomas in the kidneys</p>"
      }
    ],
    "text": "<p>Which of the following features of tuberous sclerosis is typically present during infancy but resolves by adulthood? (NEET PG 2015)</p>",
    "unique_key": "Q3451187",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012176,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><strong>Correct Answer: A. Rhabdomyomas of the heart</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Rhabdomyomas of the heart are benign tumors that represent one of the earliest manifestations of tuberous sclerosis. These cardiac tumors are typically present during fetal life or early infancy but have a tendency to spontaneously regress with age. The majority of cardiac rhabdomyomas associated with tuberous sclerosis resolve by childhood or early adulthood, often without causing significant clinical problems. While present, they can cause arrhythmias or outflow obstruction, but their natural history is typically one of regression rather than progression.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B. Angiofibromas on the face:</strong> These lesions (formerly called adenoma sebaceum) typically appear during childhood (around 3-5 years of age) and persist throughout adulthood. They are reddish-brown papules that appear in a butterfly distribution across the face and tend to increase in number and size during adolescence rather than resolving.</p><p>&nbsp;</p><p><strong>Option C. Fibromas around the nails:</strong> Periungual fibromas (Koenen tumors) typically appear during adolescence or early adulthood and persist rather than resolve. These flesh-colored nodules emerge from the nail folds, primarily of the toes but sometimes the fingers.</p><p>&nbsp;</p><p><strong>Option D. Angiomyolipomas in the kidneys:</strong> Renal angiomyolipomas are benign tumors that typically appear during childhood or adolescence and continue to grow throughout adulthood. They do not spontaneously regress and may require monitoring or intervention if they grow large or cause symptoms.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Cardiac rhabdomyomas are unique among the major manifestations of tuberous sclerosis in that they typically appear in early life and have a natural history of spontaneous regression, while most other tuberous sclerosis lesions persist or progress over time.</p>",
    "correct_choice_id": 335916,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92146,
    "choices": [
      {
        "id": 366900,
        "text": "<p><span style=\"font-size:14.0pt;\">Perform coronary angiography to rule out ischemic cardiomyopathy</span></p>"
      },
      {
        "id": 366901,
        "text": "<p><span style=\"font-size:14.0pt;\">Initiate loop diuretics and SGLT2 inhibitors</span></p>"
      },
      {
        "id": 366902,
        "text": "<p><span style=\"font-size:14.0pt;\">Start digoxin to enhance myocardial contractility</span></p>"
      },
      {
        "id": 366903,
        "text": "<p><span style=\"font-size:14.0pt;\">Initiate Ivabradine to reduce heart rate and improve diastolic filling</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 62-year-old male presents with sudden onset of shortness of breath and bilateral pedal edema. He is compliant with his antihypertensive medications, and blood pressure is well controlled. Echocardiography reveals an ejection fraction of 60%, concentric left ventricular hypertrophy, left atrial enlargement, and grade 2 diastolic dysfunction. Which of the following is the most appropriate next step to improve his condition? (INICET MAY 2025)</span></p>",
    "unique_key": "Q5832766",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012166,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Initiate loop diuretics and SGLT2 inhibitors</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient presents with Heart Failure with preserved Ejection Fraction (HFpEF). The clinical features that confirm this diagnosis include symptoms of heart failure (shortness of breath and bilateral pedal edema), ejection fraction &gt;50%, left ventricular hypertrophy, and grade 2 diastolic dysfunction. In HFpEF, no single drug improves survival, but certain medications can address symptoms and reduce heart failure hospitalizations.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Loop diuretics are the preferred choice for volume overload states and can relieve congestion, making the patient feel more comfortable. SGLT2 inhibitors (particularly dapagliflozin and empagliflozin) have been shown to reduce heart failure hospitalizations in patients with HFpEF, though they don't affect mortality.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Perform coronary angiography to rule out ischemic cardiomyopathy:</strong> This is not required at this point. Ischemic cardiomyopathy typically presents with reduced ejection fraction, not preserved ejection fraction as seen in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Start digoxin to enhance myocardial contractility:</strong> This is not appropriate since the myocardium is already contracting well (EF 60%). Digoxin does not improve survival even in HFrEF and has no established role in HFpEF management.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Initiate Ivabradine to reduce heart rate and improve diastolic filling:</strong> This is not indicated. Ivabradine has only conditional recommendations even in HFrEF, and most studies have not even evaluated ivabradine in HFpEF patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">HFpEF management focuses on symptom relief and reducing hospitalizations using loop diuretics and SGLT2 inhibitors, as no drugs improve survival in this condition.</span></p>",
    "correct_choice_id": 366901,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11289,
    "choices": [
      {
        "id": 45122,
        "text": "<p><span style=\"font-size:12.0pt;\">42 degree C</span></p>"
      },
      {
        "id": 45123,
        "text": "<p><span style=\"font-size:12.0pt;\">37 degree C</span></p>"
      },
      {
        "id": 45124,
        "text": "<p><span style=\"font-size:12.0pt;\">32 degree C</span></p>"
      },
      {
        "id": 45125,
        "text": "<p><span style=\"font-size:12.0pt;\">30 degree C</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The recommended temperature of water bath for a patient with frost bite is? (NEET PG 2020)</span></p>",
    "unique_key": "Q5064729",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012181,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. 37 degrees C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Frostbite should be managed with rapid and complete thawing using a circulating water bath maintained between 37\u00b0C and 40\u00b0C. This temperature range is optimal to reverse vascular stasis and initiate reperfusion without causing thermal injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thawing at this range is typically performed for 30 to 60 minutes and should be done only when the possibility of refreezing is excluded. Higher temperatures like 42\u00b0C are not recommended and may worsen tissue injury.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 42\u00b0C</strong>: Too hot. It exceeds the upper recommended limit and can risk thermal damage to already compromised tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 32\u00b0C</strong>: Insufficient to produce effective rewarming. Rewarming would be slow and incomplete.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 30\u00b0C</strong>: Ineffective. Tissue remains partially frozen and vulnerable to re-freezing injury.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Frostbite should be rewarmed in circulating water at 37\u201340\u00b0C for 30\u201360 minutes, avoiding hot air or dry heat.</span></p>",
    "correct_choice_id": 45123,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11215,
    "choices": [
      {
        "id": 44826,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum ceruloplasmin levels</span></span></span></span></p>"
      },
      {
        "id": 44827,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum copper levels</span></span></span></span></p>"
      },
      {
        "id": 44828,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enzyme assay</span></span></span></span></p>"
      },
      {
        "id": 44829,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Karyotyping</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child presents with hepatitis and progressive neurological degeneration. A picture of his eye has been provided below. Among the following options, what would be the initial step regarding the investigations done for this child&#39;s diagnosis? (NEET PG 2018)</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/01/screenshot-2024-10-01-113817.png\" style=\"height:203px; width:300px\" /></p>",
    "unique_key": "Q6384204",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012225,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Serum ceruloplasmin levels </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image of the eye, showing a possible Kayser-Fleischer ring, along with symptoms of hepatitis and progressive neurological degeneration, strongly suggests Wilson disease. Wilson disease is a genetic disorder affecting copper metabolism. The initial screening test in suspected cases is the measurement of serum ceruloplasmin levels, as ceruloplasmin is the primary copper-carrying protein in the blood, and levels are typically reduced in Wilson disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/nm13.jpg\" style=\"height:646px; width:700px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Serum copper levels:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This test is used to further support the diagnosis after abnormalities in ceruloplasmin levels are noted. Total serum copper is typically low in Wilson disease, but free copper is elevated due to the low ceruloplasmin levels.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Enzyme assay:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Not relevant for Wilson disease, which involves a defect in copper transport rather than an enzyme deficiency.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Karyotyping:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Also not relevant, as Wilson disease is related to mutations in the ATP7B gene, not chromosomal abnormalities.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a child presenting with hepatitis and neurological symptoms, the presence of a Kayser-Fleischer ring strongly suggests Wilson disease. The first diagnostic step is to measure serum ceruloplasmin levels.</span></span></span></span></p>",
    "correct_choice_id": 44826,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74881,
    "choices": [
      {
        "id": 298425,
        "text": "<p><span style=\"font-size:16px;\">Brugada syndrome</span></p>"
      },
      {
        "id": 298426,
        "text": "<p><span style=\"font-size:16px;\">Uhl anomaly</span></p>"
      },
      {
        "id": 298427,
        "text": "<p><span style=\"font-size:16px;\">Hypertrophic obstructive cardiomyopathy</span></p>"
      },
      {
        "id": 298428,
        "text": "<p><span style=\"font-size:16px;\">Arrhythmogenic right ventricular dysplasia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A 25-year-old woman reports episodes of palpitations and dizziness, particularly following physical activity such as playing tennis. She has experienced these symptoms multiple times over the last two years. ECG is taken and it is shown. Based on her presentation and the accompanying ECG findings, which of the following diagnoses is most likely? (INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cS5E9cv.png\" width=\"718\" height=\"300\"></span></p>",
    "unique_key": "Q5574740",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012167,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Arrhythmogenic right ventricular dysplasia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The diagnosis of Arrhythmogenic Right Ventricular Dysplasia (ARVD) is based on:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">A young patient with exertional palpitations and dizziness</span></li><li><span style=\"font-size:16px;\">ECG shows characteristic epsilon waves\u2014multiple wavelet-like appearances at the J point</span></li><li><span style=\"font-size:16px;\">T-wave inversions in V1\u2013V4 indicating RV strain/dysfunction</span></li><li><span style=\"font-size:16px;\">This condition involves fibro-fatty replacement of right ventricular myocardium in the \"triangle of dysplasia\"</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Brugada syndrome:</strong> Incorrect. It typically causes arrhythmias during rest, not exertion. ECG shows characteristic ST elevation with \"coved\" appearance in V1\u2013V3, not epsilon waves.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Uhl anomaly:</strong> Incorrect. It involves congenital absence of right ventricular musculature, which doesn't match the ECG findings or clinical presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Hypertrophic obstructive cardiomyopathy:</strong> Incorrect. ECG would show LVH with Sokolov-Lyon criteria (S in V1 + R in V5/V6 &gt; 35mm) and septal Q waves in lateral leads.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Epsilon waves on ECG are pathognomonic for ARVD, which typically presents in young people with exertional symptoms and can be a cause of sudden cardiac death, particularly common in Italy. The condition involves desmosomal mutations and progressive RV dysfunction.</span></p>",
    "correct_choice_id": 298428,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54290,
    "choices": [
      {
        "id": 216629,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fanconi syndrome presents with RTA 2</span></span></span></p>"
      },
      {
        "id": 216630,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bicarbonaturia is a feature of RTA 2</span></span></span></p>"
      },
      {
        "id": 216631,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RTA 4 is associated with hypokalemia</span></span></span></p>"
      },
      {
        "id": 216632,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RTA 4 is due to aldosterone resistance</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Choose the incorrect statement about Renal Tubular Acidosis (RTA):</span></span></span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q7060886",
    "question_audio": null,
    "question_video": null,
    "map_id": 35119679,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) RTA 4 is associated with hypokalemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Renal Tubular Acidosis (RTA) refers to a group of disorders characterized by defective renal acid-base regulation, leading to a normal anion gap metabolic acidosis. The main types of RTA include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RTA Type 1 (Distal RTA):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Characterized by a defect in the distal tubule&#39;s ability to secrete hydrogen ions, leading to acidosis and hypokalemia.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RTA Type 2 (Proximal RTA):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Involves a defect in bicarbonate reabsorption in the proximal tubule, resulting in bicarbonaturia. Fanconi syndrome, a condition involving generalized proximal tubular dysfunction, often presents with RTA Type 2.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RTA Type 4 (Hyperkalemic RTA):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This type is associated with hypoaldosteronism or aldosterone resistance, leading to impaired potassium excretion and hyperkalemia.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Fanconi syndrome presents with RTA 2:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Correct. Fanconi syndrome often involves proximal RTA (Type 2), with features such as aminoaciduria, phosphaturia, glycosuria, and bicarbonaturia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Bicarbonaturia is a feature of RTA 2:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Correct. Due to defective bicarbonate reabsorption in the proximal tubule, bicarbonaturia is a hallmark of Type 2 RTA.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. RTA 4 is due to aldosterone resistance:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Correct. Type 4 RTA is commonly due to aldosterone deficiency or resistance, leading to hyperkalemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RTA Type 4 is characterized by hyperkalemia due to aldosterone deficiency or resistance. The incorrect statement is that RTA Type 4 is associated with hypokalemia, which contradicts the typical presentation of hyperkalemia in this type of RTA.</span></span></p>",
    "correct_choice_id": 216631,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16165,
    "choices": [
      {
        "id": 64620,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cluster headache</span></span></span></p>"
      },
      {
        "id": 64621,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Subarachnoid hemorrhage</span></span></span></p>"
      },
      {
        "id": 64622,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Encephalitis</span></span></span></p>"
      },
      {
        "id": 64623,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Meningitis</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A young patient presents with a severe headache. He has never experienced a headache of this severity before. He has hypertension and nuchal rigidity on examination. Which of the following could be the diagnosis? (FMGE JAN 2023)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/27/screenshot-2024-09-27-153841.png\" style=\"height:331px; width:250px\" /></span></span></span></p>",
    "unique_key": "Q5154130",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012161,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>B) Subarachnoid hemorrhage</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A subarachnoid hemorrhage (SAH) is a life-threatening condition characterized by bleeding into the space surrounding the brain, leading to sudden, severe headaches often described as <strong>the &quot;worst headache of my life.</strong>&quot; This patient&rsquo;s symptoms, including a severe headache of sudden onset, hypertension, and nuchal rigidity (neck stiffness), are classic signs of SAH. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The CT scan provided shows diffuse blood in the subarachnoid space, which is a hallmark of this condition. The presence of blood in the sulci, gyri, and ventricles, and <strong>the star-shaped appearance of the blood distribution on the CT scan (referred to as the &quot;star of death&quot; sign)</strong> further confirms this diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. <strong>Cluster headache:</strong> Incorrect. While cluster headaches can be severe, they are typically unilateral and associated with autonomic symptoms such as tearing and nasal congestion, not nuchal rigidity or hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. <strong>Encephalitis:</strong> Incorrect. Encephalitis can present with headache, fever, and altered mental status, but it does not typically cause nuchal rigidity or hypertension, and the CT findings would differ.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. <strong>Meningitis:</strong> Incorrect. Meningitis can present with headache, fever, and nuchal rigidity, but it is usually accompanied by fever and altered mental status. The CT scan findings would show inflammation of the meninges rather than bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Subarachnoid hemorrhage presents with sudden, severe headache, nuchal rigidity, and hypertension. CT scan shows blood in the subarachnoid space, appearing as a &quot;star of death.&quot;</span></span></span></p>",
    "correct_choice_id": 64621,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11360,
    "choices": [
      {
        "id": 45406,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">600000 IU Once in 3 weeks for 5 years</span></span></span></p>"
      },
      {
        "id": 45407,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">600000 IU Once in 3 weeks for 10 years</span></span></span></p>"
      },
      {
        "id": 45408,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1200000 IU Once in 3 weeks for 10 years</span></span></span></p>"
      },
      {
        "id": 45409,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1200000 IU Once in 3 weeks for life</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An 11-year-old child who weighs 26 kg with a history of streptococcal pharyngitis presents to you with fever and arthralgia. There is no past history of rheumatic heart disease or features of carditis or valvular disease. How often is benzathine penicillin recommended for prophylaxis of rheumatic heart disease? (Neet pg 2022)</span></span></span></p>",
    "unique_key": "Q6962131",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012229,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. 600000 IU Once in 3 weeks for 10 years</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For secondary prophylaxis of rheumatic fever, especially in patients without carditis or valvulitis, the American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend administering benzathine penicillin G for either 5 years or until the patient is 21 years old, whichever is longer. Given that the child in this case is 11 years old, prophylaxis should continue until the child turns 21, resulting in a total duration of 10 years.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The dosage of benzathine penicillin G depends on the patient&#39;s weight:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For children weighing less than 27 kg, the dose is 600,000 IU.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For children weighing 27 kg or more, the dose is 1,200,000 IU.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Since the child weighs 26 kg, the appropriate dose is 600,000 IU. In high-risk areas such as India, the injection is administered every 3 weeks to ensure effective prophylaxis against recurrent streptococcal infections that could lead to rheumatic fever.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note - Treatment duration options for a patient with valvulitis:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Standard Treatment Duration</span></strong><span style=\"font-size:12.0pt\">: Patients can be treated for a total duration of 10 years or until they reach the age of 40, whichever comes later. This approach is likely considered for cases where the valve damage is not extensively severe or life-threatening.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Severe Valve Damage</span></strong><span style=\"font-size:12.0pt\">: If there is severe damage to the valves, such as cases leading to or involving heart failure, lifelong therapy is recommended. This could include ongoing medication to manage the condition and potentially surgical interventions like valve replacement to address the mechanical deficits caused by the damage.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note &ndash; </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">First-Line Therapy</span></strong><span style=\"font-size:12.0pt\">:</span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Injectable Penicillin</span></strong><span style=\"font-size:12.0pt\">: Typically administered once every 3 to 4 weeks.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Oral Alternative</span></strong><span style=\"font-size:12.0pt\"> or if the patient prefers not to receive injections, Penicillin V can be used orally at a dose of 250 mg BD.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Second-Line Therapy&nbsp;</span></strong><span style=\"font-size:12.0pt\">(For patients with Penicillin Allergy): <strong>Sulfadiazine</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Third-Line Therapy&nbsp;</span></strong><span style=\"font-size:12.0pt\">(For patients with both Penicillin and Sulfa Allergies): <strong>Macrolides</strong> (Either erythromycin or azithromycin, with erythromycin typically prescribed at 250 mg BD) </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>600000 IU Once in 3 weeks for 5 years:&nbsp;</strong>This option would be correct if the duration were 5 years, but since the patient must receive prophylaxis until age 21, this is insufficient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C.</span></strong><span style=\"font-size:12.0pt\"> <strong>1200000 IU Once in 3 weeks for 10 years:</strong> This dosage is for children weighing 27 kg or more. Since the child in this case weighs 26 kg, this dose is too high.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. 1200000 IU Once in 3 weeks for life:</span></strong><span style=\"font-size:12.0pt\"> Lifelong prophylaxis with this dosage is only indicated in patients with severe valvular damage, which is not the case here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For an 11-year-old child weighing 26 kg with a history of streptococcal pharyngitis and no carditis or valvulitis, benzathine penicillin G prophylaxis should be administered at a dose of 600,000 IU every 3 weeks for a duration of 10 years (until the child turns 21 years old).</span></span></p>",
    "correct_choice_id": 45407,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 92147,
    "choices": [
      {
        "id": 366904,
        "text": "<p><span style=\"font-size:14.0pt;\">Right hypochondrial pain</span></p>"
      },
      {
        "id": 366905,
        "text": "<p><span style=\"font-size:14.0pt;\">Non-pulsatile elevation of JVP</span></p>"
      },
      {
        "id": 366906,
        "text": "<p><span style=\"font-size:14.0pt;\">Orthopnea</span></p>"
      },
      {
        "id": 366907,
        "text": "<p><span style=\"font-size:14.0pt;\">Paroxysmal nocturnal dyspnea</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is not a symptom of cardiac failure? (INICET MAY 2025)</span></p>",
    "unique_key": "Q4793324",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012212,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Non-pulsatile elevation of JVP</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Non-pulsatile elevation of JVP is NOT a symptom of cardiac failure; rather, it is a sign of superior vena cava (SVC) obstruction. In SVC obstruction, the communication between the right atrium and jugular veins is cut off, so pressure changes in the right atrium cannot be transmitted to the jugular veins, resulting in absent pulsations. However, due to the obstruction, the JVP will be very high. The key distinction is that while elevated JVP can occur in heart failure, it should maintain pulsatile characteristics reflecting right atrial pressure changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Diagnostic Criteria</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Major Criteria</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Paroxysmal nocturnal dyspnea or orthopnea</span></li><li><span style=\"font-size:14.0pt;\">Neck vein distension</span></li><li><span style=\"font-size:14.0pt;\">Rales</span></li><li><span style=\"font-size:14.0pt;\">Cardiomegaly</span></li><li><span style=\"font-size:14.0pt;\">Acute pulmonary edema</span></li><li><span style=\"font-size:14.0pt;\">S3 gallop</span></li><li><span style=\"font-size:14.0pt;\">Increased venous pressure \u2265 16 cm H\u2082O</span></li><li><span style=\"font-size:14.0pt;\">Circulation time \u2265 25 seconds</span></li><li><span style=\"font-size:14.0pt;\">Hepatojugular reflux</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Minor Criteria</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ankle edema</span></li><li><span style=\"font-size:14.0pt;\">Night cough</span></li><li><span style=\"font-size:14.0pt;\">Dyspnea on exertion</span></li><li><span style=\"font-size:14.0pt;\">Hepatomegaly</span></li><li><span style=\"font-size:14.0pt;\">Pleural effusion</span></li><li><span style=\"font-size:14.0pt;\">Vital capacity decreased one third from maximum</span></li><li><span style=\"font-size:14.0pt;\">Tachycardia rate \u2265 120/min</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Major or Minor Criterion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Weight loss \u2265 2.4 kg in 5 days in response</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Right hypochondrial pain:</strong> This is a valid symptom of cardiac failure caused by hepatomegaly due to right heart failure and venous congestion. Patients can experience right upper quadrant pain due to liver congestion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Orthopnea:</strong> This is a classic symptom of heart failure where patients experience shortness of breath when lying flat, requiring them to sleep with multiple pillows or in a seated position due to increased venous return and pulmonary congestion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Paroxysmal nocturnal dyspnea:</strong> This is another classic symptom of heart failure where patients wake up suddenly at night with severe shortness of breath, typically occurring 2-4 hours after lying down due to fluid redistribution.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Non-pulsatile elevation of JVP indicates SVC obstruction, not heart failure; heart failure causes pulsatile JVP elevation reflecting right atrial pressure changes.</span></p>",
    "correct_choice_id": 366905,
    "solution_audio": null,
    "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92147/INI_CET_May_2025_Medicine_Q_-_8.mp4",
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "top",
    "tags": [
      "Factual"
    ],
    "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/92147/INI_CET_May_2025_Medicine_Q_-_8.mp4",
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 50966,
    "choices": [
      {
        "id": 203405,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Addison&#39;s disease&nbsp; </span></span></span></span></p>"
      },
      {
        "id": 203406,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gigantism&nbsp; </span></span></span></span></p>"
      },
      {
        "id": 203407,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acromegaly</span></span></span></span></p>"
      },
      {
        "id": 203408,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cushing&#39;s syndrome&nbsp;</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These findings are suggestive of which of the following conditions</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-113157.png\" style=\"height:174px; width:300px\" /></span></span></p>",
    "unique_key": "Q2208116",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012215,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">) <strong>Acromegaly</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: &nbsp;</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The images provided show a patient with coarse facial features, prognathism (protruding jaw), frontal bossing (prominent forehead), and prominent jaw bones. These are characteristic features of acromegaly, a condition caused by excessive growth hormone (GH) production, usually due to a pituitary adenoma.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Addison&#39;s disease:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Characterized by hyperpigmentation, hypotension, and weight loss, not by coarse facial features.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Gigantism:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Also caused by excess GH, but it occurs before the closure of the growth plates in children and adolescents, leading to increased height and growth of long bones. The facial features are not as prominent as in acromegaly.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Cushing&#39;s syndrome:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Characterized by features such as central obesity, moon face, buffalo hump, and purple striae, not by coarse facial features and prognathism.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acromegaly is diagnosed based on characteristic facial features such as coarse facial features, prognathism, and frontal bossing, resulting from excessive growth hormone production.</span></span></p>",
    "correct_choice_id": 203407,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11868,
    "choices": [
      {
        "id": 47438,
        "text": "<p><span style=\"font-size:12.0pt;\">Metoprolol</span></p>"
      },
      {
        "id": 47439,
        "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
      },
      {
        "id": 47440,
        "text": "<p><span style=\"font-size:12.0pt;\">Adenosine</span></p>"
      },
      {
        "id": 47441,
        "text": "<p><span style=\"font-size:12.0pt;\">Diltiazem</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Based on the ECG given below, which of the following drugs is NOT used in the management of the condition? (INICET NOV 2022)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103835-am.jpeg\" alt=\"\" width=\"300\" height=\"164\"></p>",
    "unique_key": "Q9844721",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012217,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Adenosine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ECG shows a case of <strong>atrial fibrillation</strong>, characterized by an irregularly irregular rhythm and the absence of distinct P waves. Instead, there are fibrillatory waves that can be seen in the baseline. Atrial fibrillation is a common type of irregular heart rhythm where the atria beat chaotically and irregularly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Adenosine is not used in the management of atrial fibrillation. It is primarily indicated for the treatment of regular narrow complex tachycardias, such as supraventricular tachycardia (SVT). Adenosine works by temporarily blocking the atrioventricular (AV) node, which can help reset the heart rhythm in cases of regular tachycardias. However, in irregular rhythms like atrial fibrillation, adenosine is contraindicated because it can induce atrial fibrillation or exacerbate the condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Metoprolol:</strong> Metoprolol is a beta-blocker used in the management of atrial fibrillation. It helps control the heart rate by slowing down the conduction through the AV node.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Amiodarone:</strong> Amiodarone is an antiarrhythmic medication used for rhythm control in atrial fibrillation. It can help to convert atrial fibrillation to a normal sinus rhythm and maintain it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Diltiazem:</strong> Diltiazem is a calcium channel blocker used to control the ventricular rate in atrial fibrillation by slowing conduction through the AV node.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Adenosine should not be used in the management of atrial fibrillation due to its potential to induce or worsen the condition.</span></p>",
    "correct_choice_id": 47440,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73067,
    "choices": [
      {
        "id": 291233,
        "text": "<p><span style=\"font-size:16px;\">Atrial contraction</span></p>"
      },
      {
        "id": 291234,
        "text": "<p><span style=\"font-size:16px;\">Ventricular contraction</span></p>"
      },
      {
        "id": 291235,
        "text": "<p><span style=\"font-size:16px;\">Passive atrial filling</span></p>"
      },
      {
        "id": 291236,
        "text": "<p><span style=\"font-size:16px;\">Tricuspid valve closure</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In the jugular venous pressure (JVP) waveform, the a-wave corresponds to: (FMGE JAN 2025)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_R4OsTx5.png\" width=\"404\" height=\"295\"></span></p>",
    "unique_key": "Q9114240",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012165,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Atrial contraction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The <strong>a-wave</strong> in the <strong>jugular venous pressure (JVP) waveform</strong> corresponds to <strong>atrial contraction</strong>. When the <strong>right atrium contracts</strong>, it causes an <strong>increase in pressure</strong>, which is transmitted backward into the <strong>jugular veins</strong>, creating the <strong>a-wave</strong>. This wave <strong>appears just before the carotid pulse and the first heart sound (S1)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Ventricular contraction:</strong> Incorrect</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>Ventricular contraction corresponds to the c-wave</strong> in the JVP waveform, caused by <strong>bulging of the tricuspid valve into the right atrium during isovolumetric ventricular contraction</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Passive atrial filling:&nbsp;</strong>Incorrect</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>Corresponds to the v-wave</strong> in the JVP waveform</span></li><li><span style=\"font-size:16px;\"><strong>Occurs during ventricular systole</strong> when the <strong>tricuspid valve is closed</strong> and blood continues to <strong>flow into the right atrium from the venae cavae</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Tricuspid valve closure:</strong> Incorrect</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>Associated with the c-wave</strong>, not a distinct wave of its own</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The <strong>a-wave in the JVP waveform</strong> corresponds to <strong>atrial contraction</strong> and is a <strong>key marker of normal atrial function</strong>.</span></p>",
    "correct_choice_id": 291233,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "FMGE",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11787,
    "choices": [
      {
        "id": 47114,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased GFR </span></span></span></span></p>"
      },
      {
        "id": 47115,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased creatinine </span></span></span></span></p>"
      },
      {
        "id": 47116,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperkalemia </span></span></span></span></p>"
      },
      {
        "id": 47117,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Proteinuria</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which among the following is the most severe manifestation of CKD? (INICET NOV 2020)</span></span></span></span></p>",
    "unique_key": "Q2124079",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012221,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Hyperkalemia&nbsp; </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperkalemia, characterized by elevated potassium levels in the blood, is particularly dangerous in CKD due to its direct impact on cardiac function. High potassium levels can disrupt normal heart rhythms, potentially leading to life-threatening cardiac arrhythmias.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Decreased GFR</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While it indicates the progression of CKD and reduced kidney function, it does not pose immediate life-threatening risks like hyperkalemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Increased creatinine</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Indicates kidney dysfunction but is a marker rather than a direct cause of severe clinical consequences.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Proteinuria</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Signifies kidney damage; however, it is more of a prognostic indicator rather than an acute life-threatening condition.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperkalemia in CKD patients is a critical condition that requires immediate medical attention due to its potential to cause fatal cardiac disturbances. Always prioritize the management of hyperkalemia in CKD patients to prevent cardiac complications.</span></span></span></span></p>",
    "correct_choice_id": 47116,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 49313,
    "choices": [
      {
        "id": 196819,
        "text": "<p><span style=\"font-size:12.0pt;\">Seen in neurosyphilis</span></p>"
      },
      {
        "id": 196820,
        "text": "<p><span style=\"font-size:14.0pt;\">Deep tendon reflexes are brisk</span></p>"
      },
      {
        "id": 196821,
        "text": "<p><span style=\"font-size:12.0pt;\">Loss of vibration sense</span></p>"
      },
      {
        "id": 196822,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute abdominal pain and visceral symptoms</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not true about Tabes dorsalis? (NEET PG 2017)</span></p>",
    "unique_key": "Q2592445",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012178,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><strong>Ans. B) Deep tendon reflexes are brisk</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>Tabes dorsalis is a late manifestation of neurosyphilis characterized by degeneration of the posterior columns and dorsal roots of the spinal cord. A hallmark feature of tabes dorsalis is the absence or significant reduction of deep tendon reflexes (hyporeflexia or areflexia), not brisk reflexes. The loss of reflexes occurs due to the interruption of the afferent limb of the reflex arc as posterior root fibers degenerate.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Seen in neurosyphilis</strong>: Tabes dorsalis is a form of neurosyphilis that occurs as a late manifestation of tertiary syphilis, usually appearing 15-20 years after the initial infection. It involves the progressive degeneration of the posterior columns of the spinal cord due to untreated syphilis infection.</p><p>&nbsp;</p><p><strong>Option C. Loss of vibration sense</strong>: Tabes dorsalis classically presents with loss of proprioception and vibration sense due to damage to the posterior columns of the spinal cord, which carry these sensory modalities. This sensory ataxia contributes to the characteristic gait disturbance.</p><p>&nbsp;</p><p><strong>Option D. Acute abdominal pain and visceral symptoms</strong>: Tabetic crises, characterized by episodes of severe pain (particularly abdominal pain, \"gastric crises\"), are a recognized feature of tabes dorsalis. These crises can mimic acute abdominal emergencies and other visceral conditions.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Tabes dorsalis, a manifestation of neurosyphilis, typically presents with absent deep tendon reflexes (not brisk reflexes), impaired proprioception and vibration sense, lancinating pain, and characteristic gait ataxia (sensory ataxia).</p>",
    "correct_choice_id": 196820,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "OlderNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16294,
    "choices": [
      {
        "id": 65136,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fludrocortisone</span></span></span></p>"
      },
      {
        "id": 65137,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hydroxychloroquine</span></span></span></p>"
      },
      {
        "id": 65138,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Methotrexate</span></span></span></p>"
      },
      {
        "id": 65139,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prednisone</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following drug is not used for a patient diagnosed with sarcoidosis with multi-organ involvement?&nbsp;(FMGE DEC 2021)</span></span></span></p>",
    "unique_key": "Q1852072",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012185,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Fludrocortisone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fludrocortisone is a mineralocorticoid and is not typically used in the treatment of sarcoidosis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sarcoidosis is an inflammatory disease that affects multiple organs, primarily the lungs and lymph glands. Treatment focuses on reducing inflammation and managing symptoms, typically with corticosteroids like prednisone and immunosuppressive agents like methotrexate and hydroxychloroquine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hydroxychloroquine:</span></strong><span style=\"font-size:12.0pt\"> Used for skin and joint manifestations of sarcoidosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Methotrexate:</span></strong><span style=\"font-size:12.0pt\"> Used for chronic sarcoidosis that is unresponsive to corticosteroids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Prednisone:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is the <strong>First-line treatment for sarcoidosis</strong> to reduce inflammation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fludrocortisone is not used in the treatment of sarcoidosis with multi-organ involvement; instead, corticosteroids and immunosuppressive agents are used.</span></span></span></p>",
    "correct_choice_id": 65136,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 54261,
    "choices": [
      {
        "id": 216513,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion and reason are true and reason is the correct explanation of assertion</span></span></p>"
      },
      {
        "id": 216514,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion and reason are true but reason is not the correct explanation of assertion</span></span></p>"
      },
      {
        "id": 216515,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion is true, reason is false</span></span></p>"
      },
      {
        "id": 216516,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion is false, reason is true</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Assertion</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Myocarditis is seen as a complication of diphtheria.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Reason</strong>: It is due to bacteremia.&nbsp;</span></span></span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q1669572",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012168,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>C) Assertion is true, reason is false</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The assertion that myocarditis is seen as a complication of diphtheria is correct. Myocarditis is a well-known and serious complication of diphtheria, often leading to significant morbidity and mortality.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The reason provided, that myocarditis is due to bacteremia, is incorrect. The complications of diphtheria, including myocarditis, are primarily due to the effects of the diphtheria toxin (toxemia), not bacteremia. The toxin affects various organs, including the heart, leading to myocarditis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myocarditis is a complication of diphtheria caused by the diphtheria toxin (toxemia), not by bacteremia.</span></span></span></p>",
    "correct_choice_id": 216515,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 16436,
    "choices": [
      {
        "id": 65704,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metastatic breast cancer</span></span></p>"
      },
      {
        "id": 65705,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiple myeloma</span></span></p>"
      },
      {
        "id": 65706,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary hyperparathyroidism</span></span></p>"
      },
      {
        "id": 65707,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Milk-alkali syndrome</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An elderly woman presented with symptoms of confusion, thirst, and abdominal pain. On exam, she had pallor and thoracic spine tenderness. Her labs showed the following findings:&nbsp;(FMGE JUNE 2022)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hb &ndash; 6.9 g/dL, </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">WBC 4000/cm&sup3; with normal DC, </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">S.Ca 13, </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">S.Cr 2.3 mg/dL, </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Total protein 9 g/dL, </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">S. Albumin 2.4 g/dL. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Urinalysis shows Bence-Jones proteins.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An X-ray of her skull is shown. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/27/screenshot-2024-09-27-132234.png\" style=\"height:281px; width:250px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the most likely diagnosis? </span></span></span></p>",
    "unique_key": "Q6792094",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012186,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Multiple myeloma</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with hypercalcemia, renal failure, anemia, and bone lesions (CRAB criteria). The presence of Bence-Jones proteins in the urine and lytic bone lesions on the X-ray further support the diagnosis of multiple myeloma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Metastatic breast cancer:</span></strong><span style=\"font-size:12.0pt\"> Can cause bone lesions and hypercalcemia but does not usually present with Bence-Jones proteins.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Primary hyperparathyroidism:</span></strong><span style=\"font-size:12.0pt\"> Causes hypercalcemia but typically does not present with anemia, renal failure, or bone lesions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Milk-alkali syndrome:</span></strong><span style=\"font-size:12.0pt\"> Can cause hypercalcemia but does not explain the other findings such as Bence-Jones proteins or lytic bone lesions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Multiple myeloma is characterized by hypercalcemia, renal failure, anemia, and bone lesions, along with the presence of Bence-Jones proteins.</span></span></span></p>",
    "correct_choice_id": 65705,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11312,
    "choices": [
      {
        "id": 45214,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase Aspirin dose</span></span></p>"
      },
      {
        "id": 45215,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase atenolol dose</span></span></p>"
      },
      {
        "id": 45216,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add a Long-Acting Nitrate</span></span></p>"
      },
      {
        "id": 45217,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add P2Y12 receptor inhibitor</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 54-year-old woman presented with chest pain. In an angiogram, her left circumflex artery was found to be stenosed, and a stent was inserted. Her current medications include ASA 75mg OD, atenolol 50mg BID, lovastatin, and lisinopril. What should be done in this scenario?</span> <span style=\"font-size:12.0pt\">(NEET PG 2021)</span></span></span></p>",
    "unique_key": "Q1953909",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012182,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D. Add P2Y12 receptor inhibitor</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">After stent placement, it is crucial to prevent stent thrombosis, which can be life-threatening. Dual antiplatelet therapy (DAPT) is the standard of care in this scenario. DAPT includes aspirin and a P2Y12 receptor inhibitor (such as clopidogrel, prasugrel, or ticagrelor). These medications work synergistically to inhibit platelet aggregation and prevent thrombus formation within the stent.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is already on aspirin 75 mg daily, so the addition of a P2Y12 receptor inhibitor is necessary to complete the DAPT regimen. This combination has been shown to significantly reduce the risk of stent thrombosis and other cardiovascular events after percutaneous coronary intervention (PCI) with stent placement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Guidelines on the duration of dual antiplatelet therapy (DAPT) &ndash; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Drug-Eluting Stents (DES)</span></strong><span style=\"font-size:12.0pt\">: A minimum of 6 months of DAPT is recommended. This therapy usually involves the use of aspirin combined with a P2Y12 receptor inhibitor (such as clopidogrel, ticagrelor, or prasugrel) to prevent clot formation around the new stent.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bare Metal Stents (BMS)</span></strong><span style=\"font-size:12.0pt\">: At least 1 month of DAPT is required. Although the duration is shorter than that for DES, it&#39;s crucial for preventing early stent thrombosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Stents Inserted for Acute Coronary Syndrome (ACS)</span></strong><span style=\"font-size:12.0pt\">: If a stent is inserted as part of treatment for ACS, the recommended minimum duration of DAPT extends to 12 months. This extended period helps manage the higher risk of thrombosis and other complications associated with ACS.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Current Patient Situation</span></strong><span style=\"font-size:12.0pt\">: <strong>Ongoing Medication</strong>: The patient is already on aspirin. A P2Y12 receptor inhibitor needs to be added to the regimen to complete the DAPT, ensuring optimal protection against clotting.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Increase Aspirin dose:</span></strong><span style=\"font-size:12.0pt\"> Increasing the aspirin dose does not provide additional benefit in preventing stent thrombosis and is not recommended as part of DAPT. The current dose of 75 mg is adequate when combined with a P2Y12 receptor inhibitor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Increase atenolol dose:</span></strong><span style=\"font-size:12.0pt\"> Atenolol, a beta-blocker, is used for managing hypertension and angina but does not prevent stent thrombosis. Increasing its dose does not address the immediate need for antiplatelet therapy post-stent placement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Add a Long-Acting Nitrate:</span></strong><span style=\"font-size:12.0pt\"> Long-acting nitrates can help manage angina symptoms but do not prevent stent thrombosis. They are not part of the recommended therapy to prevent thrombotic complications after stent placement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After stent placement, dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor (such as clopidogrel, prasugrel, or ticagrelor) is essential to prevent stent thrombosis and ensure optimal patient outcomes.</span></span></p>",
    "correct_choice_id": 45217,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 47611,
    "choices": [
      {
        "id": 190055,
        "text": "<p><span style=\"font-size:12.0pt;\">Warfarin</span></p>"
      },
      {
        "id": 190056,
        "text": "<p><span style=\"font-size:12.0pt;\">Apixaban</span></p>"
      },
      {
        "id": 190057,
        "text": "<p><span style=\"font-size:12.0pt;\">Enoxaparin</span></p>"
      },
      {
        "id": 190058,
        "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 2 month pregnant female presents with swelling in legs and diagnosed with Deep vein thrombosis, she requires anticoagulation. Which of the following is Preferred?</span>(FMGE JANUARY 2024)</p>",
    "unique_key": "Q2740727",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012189,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Enoxaparin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In pregnant women diagnosed with deep vein thrombosis (DVT), low molecular weight heparin (LMWH) such as enoxaparin is the preferred anticoagulant.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">LMWH is effective and has a better safety profile for both the mother and the fetus compared to other anticoagulants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Warfarin is teratogenic and contraindicated in pregnancy, particularly in the first trimester. Direct oral anticoagulants (DOACs) like apixaban are not recommended during pregnancy due to insufficient safety data. Aspirin alone is not effective for treating DVT.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Warfarin:&nbsp;</strong>This is contraindicated during pregnancy due to its teratogenic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Apixaban:&nbsp;</strong>DOACs are not approved for use in pregnant or lactating women due to a lack of sufficient safety data.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Aspirin:&nbsp;</strong>While it may be used for certain cardiovascular conditions, it is not effective as a sole agent for the treatment of DVT.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Enoxaparin (LMWH) is the preferred anticoagulant for pregnant women with DVT due to its safety and effectiveness, whereas warfarin, DOACs, and aspirin are not appropriate choices in this context.</span></p>",
    "correct_choice_id": 190057,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "FMGE",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11784,
    "choices": [
      {
        "id": 47102,
        "text": "<p><span style=\"font-size:12.0pt;\">A &amp; B only</span></p>"
      },
      {
        "id": 47103,
        "text": "<p><span style=\"font-size:12.0pt;\">A, B, C &amp; D only</span></p>"
      },
      {
        "id": 47104,
        "text": "<p><span style=\"font-size:12.0pt;\">A, B, &amp; C</span></p>"
      },
      {
        "id": 47105,
        "text": "<p><span style=\"font-size:12.0pt;\">B, C, &amp; D</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">You are posted as an intern in casualty. An elderly 60-year-old man is brought to you with complaints of chest pain. He has tested positive for COVID. Which of the following features will prompt you to get this patient admitted to dedicated COVID health centre? (INICET NOV 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A. Respiratory rate of 25/min</span></p><p><span style=\"font-size:12.0pt;\">B. SpO2 93%</span></p><p><span style=\"font-size:12.0pt;\">C. Multiple comorbidities</span></p><p><span style=\"font-size:12.0pt;\">D. Age</span></p>",
    "unique_key": "Q1462614",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012175,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) A, B, C &amp; D only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>A &amp; B Respiratory rate of 25/min </strong>and&nbsp;<strong>SpO2 93% </strong>: Both of these values are indicative of potential respiratory compromise, which is concerning in a COVID-19 patient. These values suggest the need for closer monitoring and possible oxygen supplementation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>C. Multiple comorbidities</strong>: Patients with multiple comorbidities are at a higher risk of severe disease and complications from COVID-19, warranting admission for close monitoring and treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>D. Age</strong>: Age is a known risk factor for severity and complications in COVID-19. Older patients, like the 60-year-old man in the scenario, generally have poorer outcomes and may benefit from hospital care.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When evaluating a COVID-19 patient for hospital admission, consider clinical signs of respiratory distress, overall oxygen saturation, presence of comorbidities, and age due to their significant impacts on disease severity and outcome.</span></p>",
    "correct_choice_id": 47103,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "CriteriaBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 24777,
    "choices": [
      {
        "id": 99069,
        "text": "<p><span style=\"font-size:11.0pt;\">Centromeric</span></p>"
      },
      {
        "id": 99070,
        "text": "<p><span style=\"font-size:11.0pt;\">Homogenous</span></p>"
      },
      {
        "id": 99071,
        "text": "<p><span style=\"font-size:11.0pt;\">Speckled</span></p>"
      },
      {
        "id": 99072,
        "text": "<p><span style=\"font-size:11.0pt;\">Nucleolar</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Identify the type of ANA staining pattern shown in the image below? (INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-152907.png\" alt=\"\" width=\"300\" height=\"294\"></span></p>",
    "unique_key": "Q9858959",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012216,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A)&nbsp;Centromeric</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The centromeric pattern is characterized by distinct dots in the nucleus, corresponding to centromeres during cell division. This pattern is associated with <strong>anti-centromere antibodies (ACA)</strong>, commonly seen in limited cutaneous scleroderma (CREST syndrome). ACA antibody&nbsp;is&nbsp; correlate with pulmonary hypertension seen in patients with limited disease.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Homogenous:</strong> Diffuse staining of the nucleus, seen with anti-ds DNA antibodies or anti-histone antibodies.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Speckled</strong>: Numerous fine or coarse speckles, a kind of quite nonspecific, associated with various antibodies such as anti-SEL70, anti-JOAN, and anti-SMITH antibodies, etc</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Nucleolar</strong>: Prominent nucleolar staining, quite nonspecific, seen with Anti-PM-Scl antibody, an overlap antibody.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Centromeric pattern in ANA staining is associated with anti-centromere antibodies and limited scleroderma.</span></p>",
    "correct_choice_id": 99069,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 47533,
    "choices": [
      {
        "id": 189743,
        "text": "<p><span style=\"font-size:12.0pt;\">Amitriptyline</span></p>"
      },
      {
        "id": 189744,
        "text": "<p><span style=\"font-size:12.0pt;\">Gabapentin</span></p>"
      },
      {
        "id": 189745,
        "text": "<p><span style=\"font-size:12.0pt;\">Carbamazepine</span></p>"
      },
      {
        "id": 189746,
        "text": "<p><span style=\"font-size:12.0pt;\">Ibuprofen</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is least useful in the management of a patient with Thalamic Dejerine syndrome?</span></p>",
    "unique_key": "Q2070538",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012188,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Ibuprofen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thalamic Dejerine syndrome, also known as Dejerine-Roussy syndrome, is characterized by chronic, intense pain on the contralateral side of the body following a thalamic stroke. The pain is often resistant to typical analgesics and requires specific management with medications that target neuropathic pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Medications useful in managing Thalamic Dejerine syndrome include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Amitriptyline:&nbsp;</strong>A tricyclic antidepressant effective in treating neuropathic pain.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Gabapentin:&nbsp;</strong>An anticonvulsant used to manage neuropathic pain.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Carbamazepine:&nbsp;</strong>An anticonvulsant also used for neuropathic pain management.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ibuprofen</strong>, a nonsteroidal anti-inflammatory drug (NSAID), is not effective for neuropathic pain and therefore is the least useful in managing Thalamic Dejerine syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A, B &amp; C</strong> are effective for neuropathic pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ibuprofen is least useful for managing Thalamic Dejerine syndrome, which requires medications that target neuropathic pain.</span></p>",
    "correct_choice_id": 189746,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 73068,
    "choices": [
      {
        "id": 291237,
        "text": "<p><span style=\"font-size:16px;\">Hypokalemia</span></p>"
      },
      {
        "id": 291238,
        "text": "<p><span style=\"font-size:16px;\">Sodium loss</span></p>"
      },
      {
        "id": 291239,
        "text": "<p><span style=\"font-size:16px;\">Metabolic alkalosis</span></p>"
      },
      {
        "id": 291240,
        "text": "<p><span style=\"font-size:16px;\">Muscle cramps</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A 50-year-old man presents with persistent hypertension. Laboratory evaluation shows elevated aldosterone levels with suppressed renin activity. Which of the following findings is not seen? (FMGE JAN 2025)</span></p>",
    "unique_key": "Q2020229",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012191,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Sodium loss</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Primary hyperaldosteronism&nbsp;</strong>presents with <strong>hypertension and elevated aldosterone levels</strong> with <strong>suppressed renin activity</strong>. Key features:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Increased sodium reabsorption</strong> \u2192 <strong>Sodium retention (NOT loss)</strong></span></li><li><span style=\"font-size:16px;\"><strong>Increased potassium excretion</strong> \u2192 <strong>Hypokalemia</strong></span></li><li><span style=\"font-size:16px;\"><strong>Metabolic alkalosis</strong> \u2192 <strong>Due to increased hydrogen ion excretion</strong></span></li><li><span style=\"font-size:16px;\"><strong>Muscle cramps</strong> \u2192 <strong>Due to hypokalemia and electrolyte imbalance</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Hypokalemia:</strong> Incorrect, as it is a <strong>classic finding</strong> in <strong>primary hyperaldosteronism</strong> due to <strong>increased urinary potassium excretion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Metabolic alkalosis:</strong> Incorrect, as it occurs due to <strong>hydrogen ion loss and potassium depletion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Muscle cramps:</strong> Incorrect, as they are <strong>commonly seen in primary hyperaldosteronism</strong>, primarily due to <strong>hypokalemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Primary hyperaldosteronism causes sodium retention (not sodium loss)</strong> and presents with <strong>hypertension, hypokalemia, metabolic alkalosis, and muscle cramps</strong>.</span></p>",
    "correct_choice_id": 291238,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "FMGE"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20254,
    "choices": [
      {
        "id": 80977,
        "text": "<p><span style=\"font-size:12.0pt;\">Parkinson\u2019s Disease</span></p>"
      },
      {
        "id": 80978,
        "text": "<p><span style=\"font-size:12.0pt;\">Prion\u2019s Disease</span></p>"
      },
      {
        "id": 80979,
        "text": "<p><span style=\"font-size:12.0pt;\">Huntington\u2019s Disease</span></p>"
      },
      {
        "id": 80980,
        "text": "<p><span style=\"font-size:12.0pt;\">Alzheimer\u2019s Disease</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An 80-year-old woman presents with a progressive decline in daily activity. She gives a history of staring into space with frequent visual hallucinations. Pathology reveals Lewy bodies in neurons. What is the most likely diagnosis? (NEET PG 2023)</span></p>",
    "unique_key": "Q8942357",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012184,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A. Parkinson\u2019s Disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence <strong>of Lewy bodies,</strong> which are <strong>aggregates of alpha-synuclein protein</strong>, in neurons suggests either Parkinson's disease or Lewy body dementia. Given the patient's symptoms of progressive decline in daily activity, visual hallucinations, and pathology findings, Parkinson's disease is the most likely diagnosis.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Lewy Bodies:</strong> These are characteristic of Parkinson\u2019s disease and Lewy body dementia. They are intraneuronal inclusions primarily composed of alpha-synuclein.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Visual Hallucinations:</strong> These are more common in Parkinson's disease and Lewy body dementia compared to other neurodegenerative disorders.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Parkinson\u2019s Disease:</strong> The diagnosis is supported by the clinical history of visual hallucinations and progressive decline, alongside the pathological finding of Lewy bodies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Prion\u2019s Disease:</strong> Typically presents with rapidly progressing dementia and myoclonus. EEG shows characteristic periodic sharp wave complexes, and CSF may show elevated 14.3.3 protein. This does not match the patient's clinical picture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Huntington\u2019s Disease</strong>: An inherited condition characterized by the classic triad of dementia, chorea, and psychiatric manifestations. This condition usually presents earlier in life and has a strong family history component.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Alzheimer\u2019s Disease:</strong> Primarily presents with memory loss and later with visual-spatial problems and the \"four A\u2019s\" (amnesia, agnosia, apraxia, aphasia). Pathologically, it is characterized by beta-amyloid plaques and tau protein tangles, not Lewy bodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of Lewy bodies in neurons and clinical features such as visual hallucinations and progressive decline in activity are indicative of Parkinson\u2019s disease.</span></p>",
    "correct_choice_id": 80977,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 55352,
    "choices": [
      {
        "id": 220869,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ezetimibe</span></span></p>"
      },
      {
        "id": 220870,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Niacin</span></span></p>"
      },
      {
        "id": 220871,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Gemfibrozil</span></span></p>"
      },
      {
        "id": 220872,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cholestyramine</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 54-year-old man with dyslipidemia has persistently elevated triglyceride levels (600 mg/dL) despite treatment with rosuvastatin. What will be the next step?<strong> </strong>(FMGE JULY 2024)</span></span></p>",
    "unique_key": "Q4938289",
    "question_audio": null,
    "question_video": null,
    "map_id": 35012190,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) Gemfibrozil</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In cases where a patient has dyslipidemia with persistently elevated triglyceride levels, particularly above 500 mg/dL, there is a significant risk of developing pancreatitis. The primary goal in such situations is to lower the triglyceride levels to mitigate this risk. Fibrates, such as gemfibrozil or fenofibrate, are the treatment of choice for reducing triglyceride levels effectively. They act by decreasing the hepatic secretion of very-low-density lipoprotein (VLDL) and increasing the clearance of triglycerides from the blood.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Ezetimibe:</strong> Ezetimibe is used to reduce low-density lipoprotein (LDL) cholesterol levels. It works by inhibiting the absorption of cholesterol in the small intestine. While it is effective for lowering LDL, it is not the first-line treatment for elevated triglycerides.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Niacin:</strong> Niacin, or vitamin B3, was previously used to lower both LDL and triglyceride levels. However, it is no longer commonly used in practice due to its side effects and lack of significant additional benefit over other treatments.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Cholestyramine:</strong> Cholestyramine is a bile acid sequestrant that is primarily used to lower LDL cholesterol. It is not particularly effective in reducing triglyceride levels and can cause gastrointestinal side effects, making it a less favorable option for this condition.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">For patients with triglyceride levels above 500 mg/dL, fibrates such as gemfibrozil are the preferred treatment to reduce the risk of pancreatitis.</span></span></p>",
    "correct_choice_id": 220871,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "FMGE",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = 'Late Night Pyq:Pyt (Medicine-3)';
        const quizFilename = 'late-night-pyq-pyt-medicine-3-ca008535.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Night PYQ"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on answer selection
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>